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Syphilis is a disease that was first described in the 1300s and now 700 years later, 
despite preventive measures and effective treatment, continues to impact on a global 
scale, with the burden falling largely on the developing world. We could find no 
recent published literature looking at predictors of outcomes in neonates born with 





The study design was a retrospective descriptive folder review of neonates born with 
symptomatic congenital syphilis at Groote Schuur Hospital (GSH) from January 
2011 to December 2013. One of the primary objectives was to address outcome as 
well as look at modifiable preventable factors. All neonates treated at GSH (inborn 
and outborn) who tested serologically positive for syphilis together with clinical 
signs of syphilis were included. Data was obtained from the National Health 
Laboratory System (NHLS) database, as well as the notification and death registers 
at GSH nursery. All data was collected in a Microsoft excel spread sheet and 




Fifty of eighty neonates (62.5%) with positive syphilis serology as well as clinical 
signs of congenital syphilis were included together with their fifty mothers. The 
majority (98%) of mothers were inadequately untreated.  Nineteen neonates demised. 
There were no statistically significant differences between the deaths and survivors 





Two significant predictors of mortality were one minute and five minute Apgar 
scores of less than five ([RR], 3.5; 95% CI 1.6-7.7 and [RR], 2.9; 95% CI 1.5-5.3 
respectively).  Hydropic neonates, tended to be sicker at birth, requiring intubation 
and inotropes, which was associated with a poorer outcome (increased risk of 
mortality). 
Conclusion 
Despite the introduction of a National Syphilis Screening programme more than 
twenty years ago together with a large proportion of pregnant women having access 
to antenatal care, congenital syphilis is still prevalent in South Africa. Failure to 
access antenatal care, poor partner tracing and a number of modifiable health worker 
related failures contribute to poor maternal diagnosis and treatment. Many neonates 
with congenital syphilis require aggressive interventions and there is a high mortality 
rate. This dissertation adds to the existing body of research particularly with regard 
to predictors of outcome in tertiary neonatal settings. Certain categories of neonates 
have a lower survival rate and guidelines about limitation of care may need to be 
considered in order to optimise resource allocation particularly in resource-
constrained settings. Further research is required to elaborate how best to develop 
protocols in these neonates.  
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The word “syphilis” originated in an ancient poem about a shepherd named Syphilis 
and was first mentioned in 1530. The disease itself however is thought to have 
precluded its current designation, masquerading previously under the guise of the 
“Great Pox”, “Morbus Gallicus (French disease)” and “Cupid’s disease” and was 
thought by some historians to have been present since the 1300s.1 There are two 
main theories regarding its origin, the “Colombian” or “New World” theory and the 
“Pre-Colombian” or “Old World Theory.” In the former, it was postulated that in the 
1400s Columbus introduced syphilis into Europe from Haiti where it was endemic. 
In the latter theory, syphilis was presumed to have originated in Africa and 
introduced into Europe prior to Columbus’s great voyage.2 Regardless of its origin, 
just over 700 years later, syphilis continues to impact on a global scale with the 
burden falling largely on the developing world.3,4,5 However, the effects on the 
developed world are by no means insignificant. In the United States, eradication of 
syphilis was a genuine possibility, with the declining rates of syphilis observed as the 
1990s ended. The increasing trend in syphilis infection rates since 2000 have led to 
the Centers for Disease Control (CDC) officially ending their syphilis elimination 
efforts as of December 2013, a mere twenty three years later.6 
 
Syphilis is a chronic infectious disease, transmitted both horizontally and vertically 
by the bacterium Treponema pallidum with humans being the only known natural 
host.7 Maternal infection is through sexual contact, via abraded skin as well as intact 
mucous membranes. There exists a high infectivity rate with an estimated thirty 







Following exposure and infection, the incubation period is three weeks (10-90 
days).8 Clinical manifestations then proceed through stages: firstly from the painless 
chancre of primary syphilis at the site of inoculation, followed by the characteristic 
syphilitic rash affecting the palms and soles of secondary syphilis, transitioning to a 
latent period and culminating in tertiary syphilis (figure 1). Latent syphilis is largely 
an asymptomatic period, which typically occurs after resolution of secondary 
syphilis (skin lesions) until cure or the onset of tertiary syphilis. Forty percent of 
untreated patients in the latent phase of infection will develop tertiary syphilis.8 The 
divisions of early and late latent syphilis are relevant in untreated cases in terms of 
the risk of relapse to secondary syphilis following infection. Early latent syphilis 
occurs in the first year following infection and is the period where ninety percent of 
first relapses occur. Late latent syphilis occurs more than a year after infection.2,9,10 
Tertiary syphilis includes neurological, cardiovascular and gummatous 
manifestations secondary to a widespread vasculitis.11 Primary syphilis, secondary 
syphilis and early latent syphilis mark the periods of greatest infectivity.12  


















2-12 weeks  
1-2 years 
10-30 years
Early syphilis Late syphilis 
+/- 21 days  
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Congenital syphilis occurs through vertical transmission from an infected mother to 
her baby. The means by which the foetus becomes infected in utero is through 
haematogenous spread, via the placenta, of an infected mother. In-utero transmission 
can occur as early as the ninth week of pregnancy, however the most common period 
of transmission is between the sixteenth and twenty-eighth week of pregnancy.13 The 
likelihood of vertical transmission increases with advancing gestation and is 
dependent on maternal timing of infection and disease stage, with early primary 
syphilis resulting in significantly higher transmission rates (70-100%) than early 
latent syphilis (40%) and late latent infection (10%).14 Furthermore, higher maternal 
antibody titres during pregnancy and at delivery regardless of treatment status is 
associated with an increased transmission rate.15 At least two thirds of neonates born 
to mothers with untreated primary or secondary syphilis will be infected.9 Adverse 
outcomes include foetal demise with spontaneous abortion (often after the first 
trimester), late-term stillbirths (30-40% of cases), preterm deliver with low birth 
weight and neonatal deaths.2,9 The longer the period between maternal infection and 
pregnancy, the more favourable the neonatal outcome (Kassowitz law) with the risk 
of infection to the neonate diminishing after four years of maternal infection even in 
the absence of maternal treatment.8,15 A single dose of benzathine penicillin is 
adequate in primary, secondary and early latent syphilis stages with decreasing 
maternal serological titres acting as an indicator of treatment success. A newborn 
may rarely be infected perinatally by contact with maternal infectious lesions during 
delivery. Postnatal transmission, from breastfeeding for example, is also exceedingly 
rare.16  
a. Clinical signs 
 
In live born neonates, infection may be clinically recognizable. However two thirds 
of live born infected neonates are asymptomatic at birth and develop signs and 
symptoms months to years later, posing a diagnostic dilemma at delivery.17 Early 
congenital syphilis refers to symptoms and signs occurring within the first two years 
of life most often between birth and three months of age. Late congenital syphilis 
manifests with signs after two years of age.7,13 
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Due to widespread spirochaetal dissemination, symptomatic neonates may have 
protean clinical signs affecting almost any organ system, explaining why syphilis is 




Figure 2. Clinical signs in congenital syphilis 9,17 
 
The most common clinical findings of early congenital syphilis include, 
hepatomegaly and/or splenomegaly, skin and mucocutaneous lesions, 
(maculopapular rash, peeling rash on the palms and soles, vesiculobullous lesions), a 
watery nasal discharge, pallor, jaundice (commonly cholestatic in nature), 
pneumonia, and non-tender generalised lymphadenopathy (LAD).12,14,17,18  The so 
called “syphilitic snuffles” (watery, occasionally blood tinged nasal discharge), 
occurs in four to twenty-two percent of neonates and usually within the first two 
weeks of birth and together with the characteristic syphilitic rash which typically 
follows it, is highly infectious, teeming with spirochaetes.9 Early congenital syphilis 
should be considered in any preterm neonate with unexplained hydrops fetalis or an 
enlarged placenta with signs of placental infection, as a result of the association of 
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Central nervous system (CNS) manifestations are usually not present at birth or in 
the immediate neonatal period and tend to occur in untreated neonates as a result of 
uncontrolled spirochaetal dissemination.  
Acute syphilitic leptomeningitis occurs in the first few months of life and presents 
similarity to bacterial meningitis with fever, irritability and a bulging fontanelle. 
Chronic meningovascular syphilis has a later presentation toward the end of the first 
year of year with focal neurologic signs (cranial nerve palsies), neurodevelopmental 
regression and seizures.8 
 
i. Placental weights 
 
As a result of placental inflammatory changes from spirochaetal transmission in-
utero the placenta is significantly heavier than expected for weight in neonates with 
congenital syphilis. In normal pregnancies, the placental weight increases with 
gestational age but decreases in relation to foetal weight.  Malan et al acknowledged 
the difficulty that this changing ratio of placental weight presented, especially in 
growth restricted or preterm neonates, as well as the underutilisation of placental 
weight as a clinical sign in congenital syphilis. They therefore constructed a 
placental weight chart for birth weight in normal neonates and assessed how this 
compared to neonates with congenital syphilis. Norms for placental weight were 
obtained from 13 601 live births generating a graph with corresponding centiles (10th, 
50th, 90th).  The placental weights for seventy-four live born neonates with congenital 
syphilis, collected over an eight year period, were then plotted onto this graph (figure 
3). These neonates were symptomatic with either clinical or laboratory changes in 
the face of positive syphilis serological testing.  Figure 3 depicts placental weight on 
the y axis and birth weight on the x axis. Each dot corresponds to placental weight in 
relation to birth weight in the seventy-four neonates with congenital syphilis, 
demonstrating that the placentae in neonates with congenital syphilis were 
significantly heavier than expected for weight (p < 0.001). This effect was most 
marked in those neonates weighing more than two kilograms. Malan et al advocated 
the routine use of placental weight graphs, especially in neonates who are 
underweight for gestational age and in areas where syphilis is prevalent.19 
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Figure 3. Relative placental weight in congenital syphilis19  
 
 
ii. Long bone changes 
 
Long bone changes, often symmetrical and multiple, are a common manifestation of 
early congenital syphilis, occurring in sixty to eighty percent of cases, and may be 
the sole manifestation in neonates born to mothers with untreated syphilis.20,21 
Findings include metaphyseal translucent bands, symmetric localized 
demineralization, osseous destruction of the medial portion of the proximal tibial 
metaphysis (Wimberger sign), metaphyseal serration (“sawtooth metaphysis,” or 
Wegener sign) as well as irregular areas of increased density and rarefaction (“moth-
eaten” appearance).22 Periostitis and cortical demineralization occur in the 
metaphyseal and diaphyseal portions of long bones with epiphyseal sparing. 
Diaphyseal periostitis is a specific and characteristic radiographic finding of 
congenital syphilis. Osteochondritis affects the joints of the knees, ankles, wrists, and 
elbows and may be extremely painful, thereby limiting spontaneous movement and 
causing “Parrot pseudoparalysis”. Bone changes are usually self-limiting showing 





b. Case definition of congenital syphilis 
 
Case definitions of congenital syphilis are not standard and differ by country as well 
as neonatal unit. Figure 4 depicts the case definitions for congenital syphilis as per 
the Centers for Disease Control (CDC).  
 
Figure 4. Case definitions of congenital syphilis as per the CDC 23 
 
c. Diagnostic testing 
 
The diagnosis of syphilis relies on serological antibody testing. However, confirming 
the diagnosis of congenital syphilis poses a diagnostic difficulty due to the effects of 
maternal transfer of IgG antibodies on both the nontreponemal and treponemal tests 
together with the absence or subtleness of neonatal clinical signs.24 Bacteriological 
confirmation is hindered by failure to culture the elusive T. pallidum together with 
the rarity of skin lesions to provide a medium for darkfield microscopy.25  
 
 




• Physical examination that is consistent with congenital syphilis OR                              	

• Nontreponemal serologic titre that is fourfold higher than the maternal titre OR	

• Positive darkfield test or PCR of lesions or body fluids	

Scenario 2: Possible congenital syphilis  	

• Any neonate with a normal physical examination and a serum quantitative nontreponemal serologic titre equal to or less 
than fourfold the maternal titre and one of the following:	

• Mother was not treated, inadequately treated, or has no documentation of having received treatment OR	

• Mother was treated with erythromycin or a regimen not recommended by the CDC OR	

• Mother received recommended treatment but less than four weeks before delivery 	

Scenario 3: Congenital syphilis less likely 	

• Any neonate who has a normal physical examination and a serum quantitative nontreponemal serologic titre equal to or less 
than fourfold the maternal titre and both of the following are true:	

• Mother was adequately treated during pregnancy, more than 4 weeks before delivery AND	

• Mother has no evidence of reinfection or relapse	

Scenario 4: Congenital syphilis unlikely	

• Any neonate who has a normal physical examination and a serum quantitative nontreponemal serologic titre equal to or less 
than fourfold the maternal titre and both of the following are true:	

• Mother was adequately treated before pregnancy AND	





Nontreponemal tests include the rapid plasma reagin (RPR) test, the venereal disease 
research laboratory (VDRL) test and the automated reagin (ART) test. Treponemal 
tests include the fluorescent treponemal antibody absorption test (FTA-ab), the 
Treponema pallidum haemagglutination (TPHA) test and most enzyme immunoassay 
(EIA) tests.  
 
The first group of tests measure antibodies directed against cardiolipin, which is a 
component of membranes and mammalian tissues. These tests provide quantitative 
results, and thereby acting as a helpful indicator of disease activity.8 Non-treponemal 
tests take up to four to six weeks to become positive following infection and one to 
three weeks after the onset of the primary lesion.26 A positive test result is more 
likely to indicate recent infection as nontreponemal tests do become negative 
following treatment, within one year in primary syphilis and within two years in the 
case of secondary syphilis.8,28 However their usefulness as a screening test is limited 
by high false negative test results, in the early period of infection, as a result of the 
prozone phenomenon, as well as in late latent infection, rendering repeat testing 
necessary. The prozone phenomenon occurs in early infection during the period of 
seroconversion when high antibody titres inhibit agglutination, resulting in a false 
negative nontreponemal screening test if undiluted serum is used. This phenomenon 
can be avoided by serial dilutions of the serum.8,28,29 A minority of patients will 
remain “serofast” with low positive titres that persist despite treatment. False 
positives may also occur in those patients with underlying connective tissue diseases 
or other chronic inflammatory illnesses as well as pregnancy per se.  
 
The second group of tests measure specific treponemal antibodies, and do become 
positive earlier in the period of infection. However, titres correlate poorly with 
disease activity and as they tend to remain positive for life, monitoring of treatment 
response is not possible. A positive test result indicates past or current infection and 
is intepreted in light of the RPR (non-treponemal test) titre. These tests are positive 





Testing algorithms differ between countries as well as neonatal units. Testing 
involves a single test from either group or combination testing with a screening test 
followed by a confirmatory test. The current WHO recommendation is for 
combination testing with a nontreponemal test followed by a treponemal test for 
screening and monitoring of therapy and establishing a presumptive diagnosis 
respectively. Some centres consider the gold standard to be the treponemal FTA-ab 
test. Because IgM antibodies become evident in the serum toward the end of the 
second week of infection and do not cross the placenta, a positive FTA-ab IgM 
indicates active neonatal disease and can be used to stage infection and provides a 
baseline for treatment monitoring; however false positives do occur.8,29   
 
Rapid tests are cost effective, simple to use, point of care devices, with a rapid 
turnaround time for results. They utilize blood, serum or plasma to test for syphilis 
antibodies with a specificity of eighty-five to ninety-eight percent and a sensitivity of 
ninety-three to ninety-eight percent. Their usefulness in resource limited settings 
cannot be emphasized enough.27 Results obtained on the same day ensures that 
maternal treatment can be instituted immediately which is an approach that has 
proven cost effective in countries with a syphilis prevalence of more than 0.15%.30 In 
the interim a formal laboratory syphilis test should be sent for confirmation. 
However, this formal result will not influence the commencement of maternal 
treatment, which is an approach essential to the prevention of congenital syphilis.  
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d. Supportive investigations 
 
i. Blood investigations 
 
Haematological findings of early congenital syphilis include anaemia (coombs 
negative haemolytic anaemia usually in the neonatal period), thrombocytopenia, 
leucopenia or leucocytosis, with or without a leukaemoid reaction. Hepatic 
derangements include cholestatic jaundice with or without a syphilitic hepatitis 
picture (elevated alkaline phosphatase (ALP) and transminases). There may be 
evidence of a disseminated intravascular coagulopathy (DIC).22 
 
ii. Cerebrospinal fluid findings 
 
The CDC recommends a lumbar puncture for cases of proven or highly probably 
congenital syphilis as well as cases of possible congenital syphilis. CSF findings in 
acute syphilitic leptomeningitis is usually in keeping with an aseptic process. A 
raised protein count (>150mg/dl) and raised white cell count (>25mm3) are 
suggestion but not diagnostic of neurosyphilis. A positive CSF VDRL test generally 
confirms the diagnosis, however false positives may occur.23 
 
iii. Other investigations  
 
Chest x-rays may be useful in those neonates with respiratory distress. “Pneumonia 
alba” is the classical term for the fibrosing alveolitis in congenital syphilis but this is 
largely a post-mortem diagnosis. Radiologically there may be evidence of a diffuse 








Penicillin is effective in all stages of syphilis and remains the drug of choice for 
treatment of neurosyphilis, maternal as well as congenital syphilis, with T. pallidum 
having yet to demonstrate resistance toward this drug.31 The risk of infection is 
terminated within twenty-four to forty-eight hours of treatment.30  
 
Treatment in the neonate depends on two factors:  
• Maternal treatment status i.e. fully treated, untreated or partially treated 
• Neonatal clinical status i.e. symptomatic or not  
 
Single doses of penicillin may be effective in the early stages of syphilis; however it 
is often clinically difficult to ascertain the maternal stage of syphilis. By definition, a 
fully treated mother should receive three doses of intramuscular penicillin weekly for 
three weeks with the last dose received more than one month prior to delivery, which 
would be more than adequate in the majority of mothers. Penicillin allergic mothers 
should be referred for penicillin desensitization. In situations where this is not 
feasible, mothers may be treated with fourteen days of a macrolide 
(erythromycin).32,33 It is important to note that erythromycin is not nearly as 
efficacious as penicillin and is unreliable in curing maternal infection or preventing 
congenital syphilis. Mothers treated with erythromycin should be presumed partially 
treated and neonates born to these mothers should be assumed to have possible 
congenital syphilis even in the absence of clinical signs.23,34 Partially treated mothers 
may have commenced treatment antenatally but it was incorrect in terms of dosing, 
duration or timing prior to delivery. An untreated mother would have received no 
treatment at all. Figure 5 demonstrates the suggested neonatal treatment algorithm as 
per the CDC.  
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Figure 5. CDC treatment algorithm for neonates (scenario numbering corresponds to case 
definition numbering as per figure 4)23 
 
 
f. Follow up 
 
In some centres recommendation for follow-up of infants diagnosed with congenital 
syphilis includes repeat serological testing performed at one, two, three, six and 
twelve months of age depending on the likelihood of neonatal infection post 
delivery. In neonates where congenital syphilis was considered less likely or 
unlikely, nontreponemal tests should be repeated until they become non-reactive or 
titres demonstrate a fourfold reduction.8 Maternal transfer of nontreponemal 
antibodies may take up to six months to disappear. Evidence of stable or rising 
nontreponemal titres after six to twelve months of age, in fully treated neonates, 
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Figure 6: CDC algorithm for follow-up testing (scenario numbering corresponds to case definition 


























Scenario 1 and 2	

Non-treponemal test 
2-3 monthly up to 
one year	

Once negative can 
stop further testing	

Stable or rising titres 
after 6-12 months: 
re-investigate and  
re-treat	

Scenario 3 and 4	
 Nontreponemal test 2-3 monthly	

If negative at 6 
months no need for 
further testing	





2. GROOTE SCHUUR HOSPITAL NEONATAL UNIT 
PROTOCOL 
 
a. Maternal syphilis  
 
The most common congenital infection in our setting is congenital syphilis. As per 
National Department of Health protocol, maternal syphilis screening should be 
routinely performed in all pregnant women at booking and if non-reactive, retesting 
should occur after thirty-two weeks.35 The National Health Laboratory Service 
(NHLS) is a public health laboratory providing diagnostic services to national and 
provincial health departments, including Groote Schuur Hospital (GSH). During the 
study period, the NHLS changed their serological testing algorithm for the diagnosis 
of syphilis. Prior to March 2013, a nontreponemal test such as RPR acted as a 
screening tool, followed by a confirmatory treponemal test (TPHA). The current 
practice (from March 2013- present) consists of performing an automated treponemal 
screening test (TPHA) at first, followed by a nontreponemal test (RPR) to determine 
disease activity. The advantages of this new testing algorithm are that it offers 
increased sensitivity and specificity, as well as reduction in time required for testing. 
FTA-ab testing is not utilised at GSH as a result of high false negative and positive 
results in our laboratory. Darkfield microscopy is not available in South Africa.  
 
b. Neonatal syphilis  
 
GSH neonatal unit protocol does not require nor utilize maternal or neonatal titres in 
order to make a diagnosis of congenital syphilis. The presence of clinical signs, as 
mentioned above, in a neonate born to a mother with syphilis whether treated or not, 
implies symptomatic congenital syphilis and is an indication for neonatal treatment. 
However, it is important to note that those neonates who are born to untreated or 
partially treated mothers who are asymptomatic at birth nevertheless receive an 
intramuscular dose of benzathine penicillin, to cover those two thirds of infected 
neonates that are asymptomatic at birth. We do not use intramuscular procaine 




 Figure 7. GSH protocol for management of syphilis exposed neonates 
 
In our unit, lumbar punctures are not routinely indicated in all neonates with 
congenital syphilis, as an abnormal result will not change management outcome nor 
treatment duration. Long bone x-rays are also not routinely performed in all exposed 
neonates. They may be requested in the event of a neonate requiring radiological 
imaging for another indication for e.g. in those intubated neonates requiring chest x-
rays to assess endotracheal tube placement or review for underlying lung pathology.  
 
Congenital syphilis is a notifiable condition. Our unit protocol dictates that 
notification of congenital syphilis occurs and that maternal sexual contacts be traced 
and treated. It also requires repeat nontreponemal serological testing in all infected 
neonates at three months of age to ensure that the test has become negative and/or 
the titre is decreasing.   











50 000 units/kg/dose,  IV, 	

12 hourly for 10 days, 	

investigation of treatment 























50 000 units/kg/dose,  IV, 	











Benzathine penicillin  	





3. STUDY MOTIVATION 
 
The World Development Report cites antenatal screening and treatment of syphilis 
as one of the most cost effective public health interventions.36 Preventative tools for 
congenital syphilis have being available for more than fifty years with a cost of less 
than $1, yet symptomatic congenital syphilis remains one of the leading causes of 
neonatal deaths.37 Even after treatment, women who contract syphilis during 
pregnancy have a 2.5 fold higher risk of adverse outcomes than uninfected women.38 
In fact, excluding morbidity, the global perinatal mortality rate from congenital 
syphilis is similar to or exceeds the perinatal deaths estimated for HIV, malaria or 
tetanus, which is a significant for a disease which is largely preventable.3 
Interestingly, advocacy and donor funds are being shunted toward Prevention of 
Mother to Child Transmission (PMTCT) programmes, yet many of the infants in 
whom HIV is prevented may die of syphilis.37 Despite these alarming facts, a survey 
of twenty-two Sub-Saharan African countries found that although universal 
screening of syphilis in pregnancy was recommended policy in seventeen countries, 
only thirty-eight percent of women attending antenatal clinics were actually screened 
and treated. None of the countries surveyed had national targets or indicators for 
monitoring the progress of antenatal syphilis screening, suggesting that it was not 
seen as a priority.39 Kuznik et al reviewed the public health burden associated with 
untreated maternal syphilis in forty-three Sub-Saharan African countries. They 
demonstrated significant mortality and morbidity (in terms of stillbirths, neonatal 
deaths, low birth weight and congenital syphilis infection) in infants born to mothers 
with syphilis across Sub-Saharan African. In fact, the public health burden associated 
with adverse pregnancy outcomes from maternal syphilis, if included, would be 
comparable to that of combined pertussis, diphtheria, measles and tetanus or 
combined neonatal infection and sepsis in the Sub-Saharan African region.40 
 
South Africa was found to be one of the few African countries with access to 
antenatal care (ANC), where ninety-seven percent of pregnant women had access to 
at least one ANC visit with 74.5 percent of those women being screened for syphilis 
infection at that visit.  
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Despite this, the total disability adjusted life year (DALY), a measure of years of life 
lost due to disability, ill health and death, due to adverse pregnancy outcomes 
resulting from maternal syphilis infection was one hundred and ten thousand, worse 
than those countries with higher syphilis prevalence rates and poorer antenatal care 
and screening.41 The implication is that in South Africa, there are other factors at 
play accounting for the higher DALY, which may be related to inadequate treatment 
or follow-up.  
 
The above factors demonstrate that in developing countries such as ours, syphilis 
remains a public health concern with congenital syphilis impacting significantly on 
neonatal as well as infant morbidity and mortality, with the resultant impact on 
resources and cost. A number of South African studies, spanning more than twenty 
years, by Pieper et al42, Ballot et al43, Delport et al44 and Saloojee et al45  have 
highlighted the burden associated with syphilis and yet despite these implications, 
syphilis as well as preventative measures against it does not appear to be a flagged as 
a health priority.  
 
Anecdotal evidence seemed to indicate an increasing number of neonates treated at 
GSH who were diagnosed with symptomatic congenital syphilis. The apparent 
increase in numbers may have been due to changes in referral pathways. Since April 
2012, Khayelithsha District Hospital opened its doors resulting in neonates from 
outside the drainage area being referred into GSH. Furthermore, policy changes 
resulted in all mothers less than thirty weeks pregnant with threatened preterm labour 
being referred directly to GSH for tocoloysis or delivery. The resultant overall 
increase in complicated deliveries at GSH may have contributed to the higher 
numbers of neonates being seen with syphilis. Nevertheless, these neonates were 
often extremely ill with an associated increased risk of morbidity and mortality.  
 
The motivation for this study was to describe the clinical features of these 
symptomatic neonates with congenital syphilis particularly pertaining to the 
maximum level of care required as well as their outcome in terms of morbidity and 
mortality. One of the primary objectives was to identify factors associated with 
symptomatic neonates, with the hope of identifying those, which may be avoidable. 
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Furthermore, the demonstration of adverse outcomes in symptomatic neonates assists 
in strengthening the argument for improving preventative measures antenatally by 
advocating early booking and therefore timeous diagnosis and appropriate treatment 
of maternal syphilis infection.  
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4. LITERATURE REVIEW 
 
The aim of the literature review was to identify the relevant literature pertaining to 
congenital syphilis with particular reference to maternal factors, neonatal clinical 
parameters, including outcomes in terms of morbidity and mortality as well as 
modifiable factors in terms of preventative strategies. Evidence with particular 
relevance to the developing world was sought.  
 
a. Literature search strategy, inclusion and exclusion criteria 
 
A search of major online medical databases (Pubmed/Medline) and an internet 
search using Google scholar was performed. The following Medical Subject 
Headings and Boolean operators were used: “congenital syphilis” AND “clinical 
signs” AND  “outcomes”. Search filters were used to include all studies published in 
the period from 1990 to the present, in English only and available online with access 
to an abstract at least.  Eighteen studies met inclusion criteria.  The articles that were 
excluded included case reports of congenital syphilis, articles pertaining to maternal 
syphilis infection predominantly, articles with a focus on diagnosis and treatment of 
congenital syphilis and articles concerning syphilis epidemiology. An article that 
reviewed congenital syphilis rates in relation to an outbreak in British Columbia was 
also excluded. The following table provides a summary of the ten international 
studies. Following on from that, is a discussion of a meta-analysis and seven studies 











b. Summary and interpretation of literature 
 
Table 1: Summary of ten international studies identified by search strategies 
1. The Incidence of Congenital Syphilis in the United Kingdom (UK): February 2010 to January 201546 
Study objective  To estimate the incidence of congenital syphilis in the UK. 
Study design Prospective, descriptive study between February 2010 and January 2015. 
Population and setting  UK 
Congenital syphilis case 
definition  
Confirmed, presumptive and possible diagnoses as per CDC criteria.  
Results 
Number of cases  17 of 175 reports (9.7%) identified as cases (3 confirmed, 13 presumptive, 1 possible).  
Neonatal factors (n=17) 12 male. 5 female. 8 premature. Median birth weight 2000g (865g-2170g). 7 asymptomatic.  
Clinical findings  Severe anaemia, hepatosplenomegaly, rhinitis, oedema, thrombocytopaenia, skeletal damage, neurosyphilis. 
One child was blind and deaf. 
Number of deaths  1 intrauterine death (IUD). 
Maternal factors (n=17)  13 white mothers. Age range 17-31 years. 2 diagnosed between 20 and 30 weeks gestation. 5 late diagnoses; 
2 diagnosed 1 month before delivery, 3 diagnosed in last month of pregnancy. 5 diagnosed at delivery. 5 
post delivery. Social concerns included drug use, prostitution, incarceration and improper health seeking 
behaviours.  
Conclusions UK incidence of congenital syphilis below the WHO threshold for elimination (< 0.5/1000 live births), 
which was related to effective surveillance monitoring.  
Comments  Primary focus was on the importance of effective and reliable surveillance programmes together with 
adequate health care services as means of achieving a low congenital syphilis incidence rate. Detail in terms 
of the individual congenital syphilis cases itself was therefore not a core aspect of this article. Despite the 
developed world setting as well as the lack of racial diversity in this cohort, study was recent and social 
factors were similar to those seen in the current South African context. 
2. Gestational and Congenital Syphilis Epidemic in the Colombian Pacific Coast47 
Study objective  To determine contributing factors to the failure of congenital syphilis prevention programmes. To determine 
clinical aspects and outcomes of infected neonates.  
Study design Retrospective electronic health record review between January to July 2011.   
Population and setting  Buenaventura, Colombian Pacific Coast 
Congenital syphilis case 
definition  
“Newborn, stillborn or abortion product born to a mother with untreated or inadequately treated gestational 
syphilis.” 
Results 
Number of cases  89 neonates and 92 mothers. 
Neonatal factors (n=89) Almost equal numbers of males and females. 16.3% were preterm and low birth weight. More than half were 
vaginal deliveries. Most were asymptomatic at the initial clinical examination.  
Clinical findings  11.2% had mucocutaneous involvement; skin lesions 2.2% and snuffles in 9%. 2 (2.2%) had poor weight 
gain. 15 (16.8%) were jaundiced.  26.5% were anaemic. 31.3% had features of a transaminitis.  
Number of deaths  7 demised (5 stillbirths, 2 early neonatal deaths). 5 were premature infants; 4 of 5 had a gestational age (GA) 
< 29 wks.   
Neonatal test results (n=81)                           
(VDRL with titres)  
Non reactive 16 (19.8%) 
< 1:4 46 (56.8%) 
> 1:8 10 (12.3%) 
> 1:16 9 (11.1%) 
Maternal factors (n=92) None known to be HIV positive. 30.4% sought no antenatal care. 26% had inadequate perinatal care. 39% 
untreated. Of those who received penicillin 5 were appropriately treated. Partner tracing poorly documented.  
Maternal test results (n=92)                        
(VDRL and TPHA)  
VDRL
< 1:4               40 (43.5%) 
> 1:8          20 (21.8 %) 
> 1:16         30 (32.6 %) 
Not done  1 (1.1%) 
TPHA 
Yes  48 (52.2%) 
No  29 (31.5%) 
Conclusion  The incidence of congenital syphilis in the 7 month time period was 6%, higher than the WHO threshold for 
elimination. Avoidable factors included poor maternal health seeking behaviour, as a result of logistical, 
financial and geographical limitations as well as delay in testing turn around times.  
Comments  Study population was a developing country with socio-economic limitations similar to those faced in South 
Africa. Of note 20% met the case definition for congenital syphilis but were in fact VDRL negative.  
3. Congenital Syphilis in Switzerland: Gone, Forgotten, on the Return48 
Study objective  To evaluate the total number of pregnant women with positive syphilis serology together with the neonatal 
outcomes and clinical features.  
Study design Retrospective study between 2000 and 2009.  
Population and setting  Zurich, Switzerland  
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Results  Out of 13,968 deliveries, positive syphilis serology was present in 9 of the mothers. 1 neonate had signs and 
symptoms of congenital syphilis.  
Conclusion 
 
The absence of routine antenatal syphilis screening programmes may lead to an increase in congenital 
syphilis incidence rates as a result of emerging infection in young women of childbearing age. 
Comments  Small cohort of positive maternal cases in the 9 year study period.  
4. Pregnancy and Neonatal Outcomes of Women With Reactive Syphilis Serology in Alberta, 2002 to 200649 
Study objective  To describe the maternal characteristics and the neonatal outcomes of pregnant women with positive syphilis 
serology.  
Study design Retrospective chart review of pregnant women in Alberta with reactive syphilis serology between 2002 and 
2006. 
Population and setting  Alberta, Canada  
Congenital syphilis case 
definition  
Probable and definitive syphilis cases as per the provincial and national case definitions.  
Results  
Number of cases  60 confirmed cases of maternal syphilis (75 pregnancies and 80 births).  
Neonatal factors (n=80) 
 
Of the 30 appropriately treated pregnancies pre-conception (32 neonates), 31 neonates unaffected and 1 
presumed to be unaffected (lost to follow-up). Of the 45 untreated mothers before conception (48 neonates), 
7 neonates had confirmed congenital syphilis, 1 had probable congenital syphilis, 3 were lost to follow-up 
and 37 were asymptomatic and unaffected. All 7 confirmed congenital syphilis cases were preterm, with a 
median gestational age of twenty-nine weeks (range 23 to 36).  
Neonatal outcomes based on maternal diagnosis and treatment  
Syphilis diagnosed prenatally  
(39 pregnancies; 42 births)  
 
41 live born infants 
• 37 had no evidence of congenital syphilis  
• 2 had evidence of congenital syphilis  (One confirmed, one probable) 
Median gestational age of maternal treatment 20 weeks (8 -36 weeks) 
• Confirmed case: untreated mother diagnosed at 21 weeks who defaulted follow-up until 
delivery (29 weeks) 
• Probable case: mother treated at 42 weeks gestational, 3 weeks < delivery 
Syphilis diagnosed 
perinatally 
(6 pregnancies; 6 births) 
6 live births 
• All symptomatic neonates 
Maternal treatment:  
• 5 mothers treated post- partum only 
• 1 untreated and died before treatment commenced 
Clinical findings  Anaemia (n=3). Long bone changes (n=3).  Hepatosplenomegaly (n=5). Rash in 3. 2 hydropic.  Long-term 
effects at age 1 to 5 years included death (n=1), microcephaly and seizures (n=1), microcephaly and visual 
impairment (n=1), visual impairment alone (n =1).  
Number of deaths  Stillborn at 27 weeks GA born to a mother diagnosed prenatally.1 early neonatal death (day 1) in mother 
diagnosed perinatally.  
Maternal factors (n=60) Median age 23 years (19-29 years). 57 non-Caucasian (80.2%). 10 Caucasian (14.1%).  30 pregnancies 
appropriately treated. 45 pregnancies no treatment or antenatal care. No statistically significant differences 
in demographics (age, ethnicity, immigrant status) between women delivering infants with congenital 
syphilis, those with uninfected children, and those treated before conception. Of the 7 neonates with 
confirmed congenital syphilis, 4 mothers accessed no prenatal care, 2 had inadequate prenatal care, 1 mother 
inappropriately labelled as having a false positive RPR whose baby was then born with signs of congenital 
syphilis.  
Conclusions  Syphilis rates seem to be increasing in a setting previously thought to have low rates. Inadequate pre-natal 
care listed as a contributing factor to this increasing rate.  
Comments  Of the 42 neonates born to fully treated mothers, only 1 had confirmed congenital syphilis, which supports 
importance of early diagnosis and effective treatment in mothers. One of the few studies that looked at long 
term outcome. Majority of neonates were asymptomatic. 
5. Outcome of Maternal Syphilis at Rajavithi Hospital on Offsprings50 
Study objective  To assess whether maternal syphilis treatment is appropriate in preventing congenital syphilis and to review 
the outcomes of infants born to mothers with untreated syphilis.  
Study design Prospective surveillance study from September 2002 to December 2003. Follow up was at 1,2,4,6 months.  
Population and setting  Bangkok, Thailand 
Congenital syphilis case 
definition  
All offsprings born to mothers with syphilis.  
Results   
Number of cases  63 mothers and 64 infants. 
Neonatal factors  (n=64) 
 
Mean birth weight 3034 +/- 495 grams. 9 infants (14.06%) identified with presumptive congenital syphilis. 
50 infants (78.13%) including the 9 presumptive cases were followed up; all had appropriate growth 
parameters. 34 (68%) were seronegative on follow-up VDRL tests.  
Clinical findings  Hepatomegaly (55.56%), desquamation of palms and soles (44.44%), radiological changes (33.33%) and 
abnormal cerebrospinal fluid (25%). 
Number of deaths  No stillbirths or deaths.  
Neonatal and maternal test 
results 
Maternal and neonatal VDRL titres were between weakly reactive to 1:32 and nonreactive to 1:32 
respectively. 
Maternal factors (n=63) 84.13% had adequate prenatal care. Mean maternal age, mean gestation age at treatment for syphilis and at 
delivery were 30.31 (+/- 5.60 years), 32.75 (+/- 6. 73 weeks) and 38.60 (+/- 1.57) weeks respectively. 23 
cases (36.51%) were appropriately treated with penicillin, inadequate penicillin treatment in 5 cases 
(7.94%), erythromycin treatment in 9 cases (14.29%). 26 mothers (41.27%) received no treatment at all.  
Conclusion Congenital syphilis rates associated with untreated or inadequately treated maternal syphilis.  
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Comments  Follow-up with assessment for serological testing was done which was not a common feature in other 
studies.  
6. Clinical Features and Follow-up of Congenital Syphilis51 
Study objective  To evaluate clinical features and outcomes of children treated for congenital syphilis  
Study design Prospective case control study from May 1997 to December 2004. Follow-up was from birth to 5 years of 
age.  
Population and setting  Porto Alegre, Brazil 
Congenital syphilis case 
definition  
Infant whose mother had untreated syphilis or inappropriately treated syphilis. Clinical findings consistent 
with congenital syphilis or a serum nontreponemal test titre 4-fold > than the mothers. 
Results   
Number of cases  379 of 24920 inborn live births (1.5%) and 19 outborn neonates met the case definition.  (Total number = 
398). Compared with 120 infants whose mothers were appropriately treated for syphilis.  
Neonatal factors (n=398)  
 
38 (9.5%) were symptomatic. 21 (5.5%) of 379 inborn infants were symptomatic (95% CI, 3.5%- 8.5%) 
which was more common in preterm infants: 21% versus 3% in full-term infants ([RR], 4.5; 95% CI, 2.6 -
7.7). 30 % evaluated between 6 months and 5 year; most had a favourable outcome.  
Clinical findings  292 (77%) had a lab/x-ray evaluation; 85 (29%) had a physical or lab/x-ray abnormality, more common in 
preterm (51%) than in full-term (26%) infants (RR, 1.97; 95% CI, 1.35-2.87).  4 most common clinical signs 
were hepatomegaly (71.1%), splenomegaly (60.5%), pallor (42.1%) and cholestatic jaundice (28.9%). 
Symptom risk found to be higher in untreated/inadequately treated mothers.  
Number of deaths  37 foetal deaths due to congenital syphilis occurred in this time period but were excluded. 11 of 398 died 
(2.8%).  1 out of 120 died.   
Neonatal test results  Serum VDRL was positive at birth in 328 (82.5%) neonates who met the case definition; negative in 70 
(17.5%) cases.  
Maternal factors (n=398) 499 neonates out of 24 920 deliveries born to mothers who tested positive for syphilis. 120 (24%) born to 
fully treated mothers. 379 neonates (76%) born to inadequately treated mothers. Maternal factors associated 
with congenital syphilis – untreated mothers with negative VDRL during pregnancy with positive test result 
at delivery (64.3%), inadequate treatment in terms of duration, drug choice, doses in relation to delivery and 
failure of titre improvement.   
Conclusion  Congenital syphilis associated with a number of negative sequelae, some irreversible. Largely due to 
inadequate maternal treatment.  
Comments  Detailed descriptive study. Some abnormality was detected by lab/x-ray evaluation in 25% of asymptomatic 
infants indicating the importance of a through clinical assessment in neonates where suspicion for congenital 
syphilis is high. Majority of cases were asymptomatic. One of the few studies that elaborated on individual 
clinical signs and that had a control population.  
7. Maternal / Congenital Syphilis in a Large Tertiary-Care Urban Hospital 52 
Study objective  To report the clinical, laboratory and serological findings of neonates and their mothers with syphilis. 
Study design Retrospective folder review for one year in 1990. 
Population and setting  Michigan, Detroit  
Congenital syphilis case 
definition  
All babies born to mothers with both a positive RPR and FTA-ab test. 
Results   
Number of cases  Out of 9 591 deliveries, 148 pregnant women (1.5%) had positive RPR and FTA-ABS tests. Control was the 
entire obstetric population.  
Neonatal factors (n=148) 
 
 
80 (54.1%) male. Mean gestational age of live-born infants was 37.3 weeks (28-42 weeks) with a birth 
weight range from 750 to 4050 g. Both the mean gestational age and the mean birth weight of the live-born 
study infants were significantly < than figures for infants born to entire obstetric population (P = 0.0001). 
75% of infants both to untreated or inappropriately treated mothers were asymptomatic.  
Clinical findings  3 infants born to untreated mothers had clinical signs of syphilis (hepatosplenomegaly, rash and anaemia) as 
compared to none in the inappropriately treated group.  
Number of deaths  6 infants were stillborn.   
Maternal factors (n=148) Mean age 25.83 years. 72 mothers (48.6%) were untreated. 31 mothers (21%) received inadequate treatment. 
45 mothers (30.4%) received adequate treatment. One third had history of substance use. Majority were 
black, multiparous women.  
Conclusion  The findings in this study suggested a resurgence of syphilis in both mothers and infants. 
Comment Despite the study being more than twenty years old in a first world setting, the social implications of 
substance abuse on maternal syphilis diagnosis and treatment is still very relevant today. One of the few 
studies with a control group.  
8. Congenital and Maternal Syphilis in the Capital of Brazil53 
Study objective  To describe the epidemiology of congenital and maternal syphilis. 
Study design Retrospective descriptive study in 2010. 
Population and setting  Brazilian Federal District 
Congenital syphilis case 
definition  
Not defined in article. 
Results   
Number of cases  137 congenital syphilis cases. 133 neonates and their mothers included (4 had inconsistent records).  
Neonatal factors (n=133) 113 (84.9%) were reported as live births. Age (average ± standard deviation) at diagnosis was 1.72 ± 12.9 
days (range 0-148 days). 116 (87.3%) were diagnosed in the first two days of life.  87 (791%) were 
adequately treated.  
Clinical findings  12 (9%) exhibited clinical signs (jaundice 4 (3%); anaemia 1 (3%); hepatomegaly 1 (3%).  
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3 (2.3 %) had long bone changes. Treatment was administered to 119 children, 79.1% (n=87) were treated 
appropriately.   
Number of deaths  3.8% (n=5) stillbirths, 3.8% (n=5) deaths, 2.3% (n=3) deaths specifically from congenital syphilis, 3% (n=4) 
as abortions. 
Neonatal test results  106 (79.7%) tested with a nontreponemal test; 78 (63%) tested positive. 
Maternal factors (n=133) Of the 133 mothers of children with congenital syphilis, highest rates (per 1,000 live births) were in mothers 
who were black (11.3/1,000 live births) or ≥40 years old (4.0/1,000 live births). 28,6% (n=38) had < than 9 
years of education; majority (54.9%, n=73) were homemakers. 116 (52.6%) mothers received prenatal care; 
70 (60.4%) diagnosed with syphilis during pregnancy. Only 1 mother was adequately treated. 100 (75.2%) 
of partners untreated.  Treatment inadequate for 88% of mothers (n=117).   
Maternal test results (n=133)  125 mothers had positive nontreponemal tests; 49 mothers had positive treponemal tests.  
Conclusion  Although mothers received prenatal care, maternal diagnosis and treatment of syphilis was inadequate due to 
poor partner tracing. Factors associated with higher rates of congenital syphilis included black/brown skin, 
low socioeconomic status as well as maternal age between 20-30 years.  
Comments  Brazil is a developing country with a similar socioeconomic structure to South Africa. This study 
acknowledges the public health concerns associated with rising syphilis rates and highlights the inadequacies 
in maternal prenatal care and therefore maternal treatment of syphilis.  
9. Maternal and Congenital Syphilis Under-reported and Difficult to Control54 
Study objective  To identify and to describe reported and unreported cases of congenital and maternal syphilis. 
Study design Retrospective descriptive study from January 2007 to July 2013. 
Population and setting  Brazil 
Congenital syphilis case 
definition  
Every child, miscarriage, or stillbirth with clinical or serologic or microbiological evidence of syphilis born 
to a mother with syphilis that had not been treated or had received inadequate treatment.  
Results   
Number of cases  54 cases of congenital syphilis. 93 cases of maternal syphilis.  
Neonatal factors (n=54) 88.9% asymptomatic. No cases of co-infection with HIV/AIDS recorded. 51.8% treated as directed. Follow-
up was poor.  
Clinical findings  4 (7.4%) had clinical signs. 77.8% maintained adequate weight for gestational age. 
Number of deaths  16.1% progressed to abortion or stillbirth. 
Neonatal test results  24 (25.8%) were not tested for syphilis. 26 (27.9%) were positive. 22 (23.7%) were negative.  
Maternal factors (n=93) Predominantly mulatto, between 21 and 30 years; single marital status. 43% attended minimum number of 6 
appointments; however, mostly late diagnoses (62.4%). No cases adequately treated. 33.3% of pregnant 
women received no treatment. 6.5% of syphilis in pregnant women notified. 98% of partners untreated.  
Maternal test results  Not provided. 
Conclusion  Vertical transmission of syphilis is largely a product of inadequate maternal antenatal care, poor reporting of 
syphilis and lack of effective partner tracing.  
Comments  This is the most recently published study (2016). Six years after the study by Muricy et al also from Brazil, 
published in 2015, but based on data from 2010, the same modifiable inadequacies concerning maternal 
syphilis infection are showcased.54 This is unreasonable for a largely preventative disease where neonatal 
outcomes are known to be unfavourable.  
10.  Congenital Syphilis at Goroka Base Hospital: Incidence, Clinical Features and Risk Factors for Mortality55 
Study objective  To describe the clinical features, incidence of congenital syphilis and risk factors for death. 
Study design Prospective study design from January 1998 to December 1999. 
Population and setting  Papua New Guinea. 
Congenital syphilis case 
definition  
Symptoms of congenital syphilis in the presence of a positive VDRL test. 
Results   
Number of cases  67 affected neonates and children. 
Neonatal factors (n=67) 55% were male. Median birth weight 2.4 kg (interquartile range 1.7-3.1 kg). 18 were < 2 kg; 9 weighed < 
1.5 kg.  
Clinical findings  Common clinical findings were anaemia, splenomegaly, hepatomegaly, jaundice and anaemia. Mortality in 
first admission was lower in babies whose mothers received hospital antenatal care: 3 of 18 died, compared 
with 14 deaths in 31 children of mothers not receiving hospital antenatal care (Fisher’s exact test = 0.06). 
 
Number of deaths  19 deaths (first admission). 3 deaths (follow-up period). Total mortality rate 33%.  Relative risk for death 
from syphilis in babies weighing < 2 kg was 3.35 (95% confidence interval 2.39-4.71). 
Neonatal test results  Not elaborated on.  
Maternal factors (n=67) Antenatal care attendance recorded for 49 of the 67 mothers. 25 (51%) had at least 1 antenatal visit; 24 
(49%) did not receive any antenatal care. 25 booked mothers. 
Maternal test results  15 babies with congenital syphilis born to 69 mothers with a positive VDRL and TPHA. 1 of the 18 mothers 
who was treated delivered an affected baby; 14 affected babies born to mothers who did not receive 
treatment.  
Conclusion  Syphilis contributed substantially to mortality in low birth weight babies which was statistically significant.  
 
Comments  Older study but one of the only ones assessing risk factors for mortality. Case definition for syphilis same as 
out study.  
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Pooled estimates across six studies from a systematic review and meta-analysis of 
adverse pregnancy outcomes among untreated women with syphilis and women 
without syphilis demonstrated foetal loss and stillbirth being twenty-one percent 
more frequent, neonatal deaths being 9.3% more frequent and prematurity or low 
birth weight being 5.8% more frequent among women with syphilis. Mortality was 
higher (10%) in the single study that estimated infant death among infants of mothers 
with syphilis. Data from three of the six studies was from an African context.56 
Further insight into the African perspective of congenital syphilis was provided by 
Kruger et al in the form of a retrospective folder review of all cases diagnosed with 
congenital syphilis over a thirty month period in a single centre in rural Tanzania. 
Despite the small number of cases (14), the study was important in identifying two 
factors; the difficulty in diagnosing congenital syphilis in resource poor settings as 
clinical signs were not always overt at birth as well as the value of maternal 
screening in pregnancy to ensure timeous treatment of maternal syphilis, a recurring 
theme in many of the studies mentioned above.4  
 
Pertaining to a South African context, a cross sectional study by Bam et al in the 
early nineties in Bloemfontein assessed the prevalence of syphilis in both mothers 
and their babies. The study found a fifteen percent maternal seroprevalence rate and 
similar to the studies mentioned above failure of maternal treatment was listed as a 
contributory factor to congenital syphilis.57 A study performed in a large tertiary 
urban hospital in Gauteng in the early nineties, reviewing notification of congenital 
syphilis over a one-year period, found that two hundred and nine (4.7 %) deliveries 
were in syphilis positive mothers. Two hundred neonates met the CDC case 
definition of congenital syphilis; twelve pregnancies resulted in stillbirths, eight in 
incomplete abortions and two in early neonatal deaths.43 An additional study from a 
tertiary neonatal unit in the Western Cape that looked specifically at chest radiograph 
features of congenital syphilis, described twenty cases of congenital syphilis over a 
two year period. Hepatomegaly, jaundice and anaemia were the commonest clinical 
signs; radiographic changes (extensive periositis, increased density of the rib cage, 
scapula, clavicles and humerus) were found to have a positive predictive value of 
more than seventy percent.42  
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Insight into the rural impact of syphilis was from a South African study by 
Wilkinson et al, which demonstrated that adverse pregnancy outcomes were almost 
twelve times more likely in woman with syphilis than in seronegative woman.58 
Neonates with symptomatic congenital syphilis often require longer hospital 
admissions and are more likely to require neonatal intensive care admissions.59 In 
one large South African referral hospital, it was noted that on average, one neonatal 
ICU bed out of a total of twelve is occupied by an infant with syphilis.45  
 
c. Identification of gaps and need for further research  
 
The above literature suggests that syphilis is on the rise in both developed as well as 
developing countries. Alarmingly, studies more than twenty years ago noted the 
resurgence of syphilis that, at present, remains unyielding.  Untreated or inadequately 
treated maternal syphilis is a product of deficient prenatal care and is compounded 
by poor socioeconomic conditions. Despite the rising trend as well as case fatality 
rates of symptomatic syphilis in South Africa as high as thirty-eight percent, we 
could find no recent published literature looking at predictors of outcomes in 
neonates born with symptomatic congenital syphilis, especially in the context of a 
tertiary neonatal setting.45 This study is therefore valuable in that it would not only 
add new information about an age-old disease, but it may act as an important source 
for development of guidelines regarding limitation of care in certain categories of 
neonates with congenital syphilis who have a low survival rate. This is turn may 
have implications on resource allocation and protocol development in the future. 
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a. Primary objectives 
 
i. What was the outcome for symptomatic neonates in terms of mortality and 
morbidity?  
 
Morbidity will be assessed as: 
• Need for respiratory support (Intermittent positive pressure ventilation 
(IPPV), high frequency oscillation and ventilation (HFOV), continuous 
positive pressure ventilation (CPAP)  
• Level of care required (intensive care unit [ICU], high care, low level unit) 
• Associated haematological abnormalities necessitating blood products 
• Seizures /neurological deficits  
 
ii. Were there identifiable modifiable factors, which resulted in neonates being born 
with congenital syphilis? 
  
• Patient factors: Unbooked mothers, mothers who defaulted follow-up visits 
• Clinical/personnel factors: failure by health care provider to act on positive 
results or syphilis testing not done 
• Health facility factors: no rapid tests (out of stock etc.) 
 
b. Secondary objectives 
 
i. What is the incidence of symptomatic congenital syphilis per number of total 
deliveries at GSH nursery and how does this compare to regional, national and 
international figures, taking into account that GSH is a referral centre? 
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ii. What were the clinical signs (including placental weights), radiological signs as 
well as laboratory findings in neonates born with congenital syphilis?  
iii. What was the short and medium term neurodevelopmental outcome of these 
neonates? 
• Ultrasound scans acted as proxy for short-term neurodevelopmental outcome, 
assessing presence of intraventricular hemorrhages (IVH) or periventricular 
leukomalacia (PVL) 
• Twenty week infant neurodevelopmental assessment (INA) assessed medium 
term neurodevelopmental outcome 
• Follow-up admissions 
 
iv. Was serological syphilis testing repeated at three months of age as per the GSH 




a. Study design and setting 
 
The study design was a retrospective descriptive folder review of neonates with 
symptomatic congenital syphilis admitted to GSH from the 1st January 2011, to the 
31st December 2013.  GSH is a tertiary neonatal unit with an average of five 
thousand five hundred live births per annum and acts as the primary referral centre 
for the Metrowest Area of Cape Town.  The Metro West geographical service area 
includes the sub-districts of Klipfontein, Mitchell’s Plain, Southern and Western with 




i. Inclusion criteria 
 
All neonates treated at GSH (inborn and outborn) who tested serologically positive 
for syphilis together with clinical signs of syphilis were included. As per our unit 
protocol, serological testing for syphilis is always performed in symptomatic 
neonates (i.e. those with hepatosplenomegaly, pallor, hydrops etc.).  
 
ii. Exclusion criteria 
 
We have excluded those neonates with absent clinical signs of congenital syphilis in 
the face of positive syphilis serology (non-treponemal and treponemal tests). As it is 
not routine unit practice to test these neonates, some reasons may include incorrect 






All syphilis serological tests (RPR, TPHA, FTA-Ab) performed at GSH in the 
paediatric population between 1st January 2011 and 31st December 2013 were 
obtained from the NHLS database in the form of a Microsoft excel spread sheet. This 
included all children tested for syphilis at GSH from birth up to and including 4 
months of age for whom age was recorded. Permission, as well as the serological test 
result spreadsheet, was obtained from the clinical head of microbiology. All neonates 
with positive syphilis serology were identified. As congenital syphilis is a notifiable 
condition in South Africa, the notification register at GSH nursery (GW17/5) as well 
as the death register were used to supplement the laboratory results in order to ensure 
comprehensiveness and inclusivity of all congenital syphilis cases. The folders of all 
neonates who tested serologically positive for syphilis together with all neonates 
notified for congenital syphilis as well as those neonates whose cause of death was 
recorded as congenital syphilis as per the death register were then obtained from 
hospital records and the relevant data captured.  
 
d. Data collection 
 
i. Data collection sheet 
 
Each neonate had a standardized data collection sheet onto which the relevant 
information was captured, as documented by the attending physician (see appendix 
1). The assumption was that undocumented information was not asked or performed 







ii. Data sources 
 
Patient folders acted as the primary means of obtaining data. In instances where 
results were undocumented, the NHLS database, via patient folder numbers, was 
utilised to locate those missing results. Similarly, this database was used to assess 
whether placental histology was sent as well as to follow-up six-week HIV PCR 
results and syphilis serological testing at three months of age.  
 
Information regarding neurodevelopmental outcome, was obtained through the high-
risk clinic register. High-risk clinic is where the first neurodevelopmental screening 
occurs at twenty weeks corrected gestational age (GA) in those neonates who had a 
protracted and complicated clinical cause (intubation for prolonged periods, extreme 
prematurity, recurrent apnoeas, seizures, encephalopathy).  The high-risk register 
identified those neonates who defaulted neurodevelopmental follow-up and in those 
who did follow-up the resultant neurodevelopmental outcome was documented. The 
electronic Clinicom system, which provides information regarding admissions, 
discharges and deaths in the Western Cape hospitals, was used to identify those 
neonates who had subsequent admissions to hospital following discharge, utilizing 
folder numbers and dates of birth. Their relevant folders were then sought and their 
development as assessed at that admission was documented.  
 
e. Statistical analysis 
 
Data collected was transferred from each information sheet onto a Microsoft excel 
database, which was identical for each neonate. Names were omitted and information 
was linked via patient initials.  
 
All data was analysed descriptively which included means and standard deviations 
for normally distributed data and medians and inter-quartile ranges for non-normally 




Descriptive statistics and graphical representation in the form of bar graphs, pie 
charts and box and whiskers plots were used to explore data and results using 
Microsoft excel. Microsoft StatPlus was used for statistical calculations. In terms of 
statistical analysis, relative risks with 95% confidence intervals and p values were 
used to compare outcomes between deaths and survivors. Bivariate analysis was used 
to compare differences in the death and survivor groups; Chi-squared tests for 
categorical data, T-tests for normally distributed numeric data and the Mann Whitney 
U test for non-parametric numeric data.  
 
f. Ethical considerations 
 
Folders were reviewed at GSH and never removed from the premises. No written 
parental consent was obtained as this was a retrospective study and all identifying 
data was removed. Approval from the Health Sciences Faculty Human Research 
Ethics Committee (HREC) was obtained (HREC 263/2014). 
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Figure 1. Summary of results   
 
Eighty neonates tested serologically positive for syphilis with either a nontreponemal 
or treponemal test. The notification and death registers did not yield any additional 
cases. The folders of all eighty neonates were reviewed which included a set of 
dichorionic diamniotic twins.  
 
Included neonates: Fifty neonates with positive syphilis serology as well as clinical 
signs of congenital syphilis were included together with their fifty mothers.  
Nineteen (38%) of the symptomatic neonates demised (figure 1). 
 
Excluded neonates: Thirty neonates who were noted to be asymptomatic without 
clinical signs of congenital syphilis, did not meet the case definition, and were 
therefore excluded. This included one of the twins (the other twin was symptomatic).  
All thirty neonates did receive a single intramuscular dose of penicillin at delivery.  
 
80 neonates with 
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a. Maternal characteristics 
 
Mothers resided in a wide variety of suburbs with no particular residential area or 
geographical location demonstrating a higher number of cases. However, forty-five 
(90%) mothers were coloured and five (10%) were black. The mean maternal age 
was 24.78 years (+/- 5.5 years). Forty-three (86%) mothers were under the age of 
thirty. The majority of mothers (60%) were multiparous (figure 2).  
 
Figure 2. Maternal gravidity (G) (n=50) 
 
Twenty-eight (56%) mothers were unbooked and therefore received no antenatal 
care. The mean age of the unbooked mothers was 24.8 years (+/- 4.5 years). Ten 
unbooked mothers were primiparous.  One twenty-three year old mother whose 
current pregnancy was her sixth, and who delivered a term infant, was unbooked. 
The reasons for being unbooked were not documented for any of the twenty-eight 
mothers.  
 
Twenty-two (44%) mothers did book. Fifteen of the sixteen mothers who booked and 
whose gestation at booking was known, booked in the second trimester or later with 
only one mother booking early at seven weeks gestation (figure 3). The median 





























Figure 3. Gestation at booking (n=22) 
 
Twelve mothers (24%) were substance users. Ten used methamphetamines; one was 
a regular ethanol user and one smoked heroine.  All twelve of these mothers were 
unbooked with the mean age of twenty-five years old (+/- 5.7 years).  
 
Seven mothers were HIV positive with two on recommended antiretroviral therapy 
(ART) as per protocol at that time. All seven mothers were diagnosed with the 
current pregnancy. Four of the seven mothers were unbooked. Two mothers, who did 
book at twenty-two and thirty-one weeks respectively, with CD4 counts of 422 
cells/μL and 298 cells/μL respectively, were on prophylaxis in the form of 
zidovudine as per the National Department of Health protocol at that time. The third 
mother with a CD4 count of 601 cells/μL who did book had an unknown gestation at 
booking. However it was known to be late and close to the timing of delivery, 
explaining why neither maternal prophylaxis nor ART was initiated. No other CD4 or 















































i. Maternal test results 
 
Figure 4 summarises the maternal syphilis serological test results.  
 
Figure 4: Summary of maternal serological test results 
 
The following table depicts the syphilis serological test results of the twenty-eight 
unbooked mothers (table 1). One unbooked mother had no syphilis testing 
performed. In the remaining twenty-seven mothers, testing was performed at the time 
of delivery.  
 
Tests and titres Number (n=28) 
Nontreponemal test 
RPR positive 22 
RPR negative 5 
RPR unknown 1 
RPR titres 






TPHA positive 2 
TPHA negative  0 
TPHA not done 26 
RPR and TPHA positive 2 
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The following table depicts the syphilis serological test results of the twenty-two 
booked mothers (table 2). 
Table 2. Results of the twenty-two booked mothers during pregnancy  
 
Of the eleven mothers who tested negative antenatally, four tested positive on 
subsequent test results - three at delivery and one post-delivery (figure 4). The 
duration between negative and positive test results was known for two of the 
mothers, two and half months between testing for one mother and two weeks for the 
other. The remaining seven mothers, who tested negative during pregnancy, were 
presumed infected through the screening of their symptomatic babies who tested 
positive for syphilis as part of the investigative work up for congenital infection.  
The gestation at which syphilis testing was negative was known for seven of the 
eleven mothers with six of the seven testing negative before thirty-two weeks 
gestation with only one mother undergoing retesting after thirty-two weeks (table 3). 
In the remaining four booked mothers who tested negative at an unknown gestation 
antenatally, two had repeat tests at delivery; one was positive on a rapid test and the 
other mother was positive on a RPR test with a titre of 1:64. The GA of their babies 
was twenty-eight and thirty-six weeks respectively. Another mother had a 
documented “possible syphilitic rash” on her antenatal card- however, her test was 
neither repeated, nor was she treated with penicillin. 
Table 3. Gestation at which maternal syphilis serology was negative (n=7) 
Tests and titres Number (n=22) 
Nontreponemal test 
RPR positive  11 
RPR negative  11 
RPR titres  
Rapid test (no titre) 2 





TPHA positive  0 
TPHA not done 22 
Gestation at negative testing in weeks  Was repeat testing performed after 32 weeks gestation? 
Result if repeated 
7 (n=1) No   
22 (n=1) No  
23 (n=1) Yes at delivery at 33 weeks (Titre 1:16) Positive  
23 (n=1) No   
24 (n=1) No  
31 (n=1) No   
33 (n=1)  Yes at delivery at 35 weeks (Titre 1:64) Positive  
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Therefore, syphilis was serologically confirmed in thirty-seven (74%) of mothers. 
However, more than seventy percent of these mothers were diagnosed at delivery 
with 24% being diagnosed within two weeks of delivery (figure 5).  
 




ii. Maternal treatment 
 
The overall maternal treatment rate was poor with just one mother being fully treated 
(figures 6, 7, 8).  
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delivery	






















Figure 7. Maternal reasons for being untreated (n=39) 
 
Figure 8. Maternal reasons for being partially treated (n=10) 
 
 
The seven mothers who booked late were partially treated as they delivered before 
treatment was completed; two booked at thirty-one weeks gestation and delivered at 
thirty-three and thirty-four weeks respectively. Two mothers who booked at thirty-
two and thirty-three weeks respectively both delivered two weeks later and two 
mothers who booked at thirty-six and thirty-seven weeks respectively both delivered 
a week later. The exact gestation at booking was unknown for the seventh mother but 
it was known to be late in pregnancy as the baby’s gestational age was thirty-eight 
weeks and maternal treatment was not yet completed. The two partially treated 
mothers with preterm deliveries booked at twenty-four and twenty eight weeks 
gestation respectively and delivered within a week.  
 
Despite syphilis being serologically confirmed in more than seventy percent of 
mothers, the inadequate maternal treatment rate can be explained by the timing of 
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The only mother who tested serologically positive for syphilis and was fully treated 
was in turn the only mother who booked more than one month before delivery at 
twenty-two weeks, ten weeks prior to delivery. However her partner was not treated. 
Unfortunately the other two mothers who booked at seven weeks and twenty-two 
weeks respectively tested negative for syphilis and did not have repeat testing 
performed and were therefore untreated.  
 
Partner tracing information was poorly documented. Four partners (8%) were traced 
and referred for treatment with the rest undocumented. 
 
 
b. Neonatal characteristics 
 
Twenty-two (44%) neonates were born at GSH (inborn). Of the twenty-eight (56%) 
outborn neonates three were born at home. The remaining twenty-five were born in 
district and regional hospitals as well as midwifery obstetric units (MOUs) and 
referred into GSH. Being outborn had no statistically significant effect on neonatal 
mortality (p = 0.83). Twenty-nine (58%) were male neonates and twenty-one (42%) 
were female. Thirty-one neonates (62%) were born via normal vertex deliveries with 
caesarean sections comprising the remaining thirty eight percent.  
 
The median gestational age was thirty-four weeks based on Ballard scoring 
performed at birth (IQR 31-36.5 weeks) (figure 9).  Forty-two (84%) neonates were 
less than thirty-eight weeks gestational age at birth. The mean birth weight was 1933 
grams (+/- 685g) (figure 10). 
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Figure 9. Gestational age (n=50) 
 
Figure 10. Birth weight (n=50) 
 
Twenty-five neonates (50%) required resuscitation at birth. Ten required basic 
resuscitation in the form of stimulation and CPAP. Twelve required intubation and 
seven needed cardiorespiratory resuscitation (CPR). Two neonates, who required 
intubation and CPR, also required adrenaline. These twenty-five neonates had a 




















































































































 Figure 11: Outcome of the HIV exposed neonates (n=7) 
 
The mean birth weight for the seven HIV exposed neonates was 2154 grams          
(+/- 893g) with a median gestational age of 33 weeks (IQR 32-36.5 weeks). 
Gestational age and birth weight were similar in the HIV exposed and HIV 
unexposed groups (p = 0.9 and p = 0.36 respectively) (figure 12). 
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Of the seven HIV exposed neonates, two who were born to unbooked mothers with 
no maternal ART exposure antenatally, demised on day two and day nine of life 
respectively.  The first neonate was extremely unwell from birth; she was outborn at 
a MOU with low Apgars of one and three requiring extensive resuscitation. She was 
premature at thirty-six weeks GA, anaemic (Hb= 9g/dl) and thrombocytopenic 
(platelets = 44 x 109/l) with signs of marked respiratory distress requiring HFOV and 
inotropes until the day of demise on day two. The second neonate was premature at 
thirty-three weeks GA born via a caesarean section for cord prolapse; she had a birth 
CRP of 154 mg/l with signs of respiratory distress and also required HFOV and 
inotropes until the day of demise. All seven neonates received prophylaxis either in 
the form of single dose nevirapine (n=2) or dual prophylaxis with nevirapine and 
zidovudine (n=5) as per the unit protocol at the time. One neonate, born to an 
unbooked mother with no ART exposure antenatally was infected, diagnosed on a 
forty eight hour HIV PCR test and initiated on ART nineteen days post delivery. 
Based on the timing of diagnosis this was likely an in-utero transmission. Two 
neonates were known to be negative on a six week HIV PCR and two had unknown 
HIV PCR results at six weeks (figure 11). 
 
ii. Clinical signs 
 
Figure 13 demonstrates the clinical signs present in the symptomatic neonates as 
documented, by the attending physician, on initial presentation. Oedema was 
presumed to denote body swelling with interstitial fluid accumulation in the absence 
of compartmental fluid collections. Hydrops fetalis implied fluid collection in two or 
more sites such as pleural effusions, pericardial effusions or ascites and was by 
definition non-immune in origin. Petechiae, jaundice and pallor were clinical 
assessments of presumed thrombocytopenia, elevated bilirubin levels and anaemia 
respectively. Intrauterine growth restriction (IUGR) referred to those neonates whose 
birth weight and/or length and head circumference plotted below the third centile for 
gestational age. Hepatosplenomegaly (HSM) referred to any documented palpable 
liver AND spleen. Respiratory distress was defined as clinical signs of distress such 
as tachypnoea and inter/subcostal recessions together with the need for supplemental 
oxygen in any form within twenty-four hours of birth.  
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Shock was a clinical assessment based on signs of poor perfusion with supporting 
evidence from blood pressure measurements and arterial blood gases. Murmurs 
presumed to be a patent ductus arteriosus (PDA) were usually clinical assessments. 
Persistent pulmonary hypertension of the newborn (PPHN) was defined as pre and 
post ductal oxygen saturation differentials of more than ten percent.  Four neonates 
had seizures; two were term neonates with electrical seizures diagnosed on a cerebral 
function monitor (one demised and one survived). The remaining two neonates with 
clinical and electrical seizures both demised; one was term with severe meconium 
aspiration syndrome and the other was a septic preterm neonate with birth asphyxia, 
requiring intubation and CPR at delivery. None of the four neonates had a lumbar 
puncture performed.  
 
 
Figure 13. Clinical signs in the fifty symptomatic neonates  
 
       
      General:  
      IUGR 13 (26%) 
      Hydropic 11 (22%) 
      Generalised LAD 2 (4%) 
      Petechiae 24 (48%) 
      Jaundice 21 (42%) 
      Pallor 22 (44%) 
      Oedema 2 (4%) 
 
     
 
     Cardiac: 
     PDA murmur 8 1(6%) 
     Shock 17 (34%) 
     PPHN 6 (12%) 
 
    Abdomen:  
    HSM 40 (80%) 
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Respiratory distress was the commonest clinical sign. Figure 14 depicts the outcome 
in these neonates comparing premature neonates and term neonates.   
Figure 14. Outcome of neonates with respiratory distress (n=47) 
 
There were more preterm neonates with respiratory distress than term neonates. 
Premature neonates were not significantly more likely to be intubated than term 
neonates ([RR], 1.2; 95% CI 0.5-2.5). However the need for intubation in preterm 
neonates had a statistically significant effect on mortality  ([RR], 11.6; 95% CI 1.7-
78.9). 
 
Placental weights were known for thirty-seven (74%) of the fifty symptomatic 
neonates and were plotted on the placenta for birth weight graph created by Malan et 
al (figure 15).19 A large number of placentae were noted to be relatively heavier than 
birth weight and plotted on or above the 90th centile (n=27). Of the neonates 
weighing more than 2 kg, all but two plotted above the 90th centile, in keeping with 




























           
 





Figure 15.  Placental weight for birth weight 
 
 
iii. Laboratory investigations 
 
One acutely unwell neonate had no serological test results other than a positive RPR 
for syphilis. Other blood tests taken were insufficient, and due to demise on day one 
of life, repeat testing could not be performed. All other forty-nine neonates had a 
FBC and CRP performed.  Twenty-one neonates were anaemic and the median 
haemoglobin at birth for these neonates was 9.5 g/dl (IQR 1.8-10.5 g/dl). Twenty 
neonates were thrombocytopenic at birth and the median platelet count for these 
neonates was 27 x 109/l (IQR 16-37.5 x109/l). Figure 16 depicts the commonest 
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 Figure 16. Abnormal laboratory investigations 
 
The commonest laboratory derangement was hypoglycaemia (54%). Of these 
twenty-seven neonates, twelve had a single hypoglycaemic episode post delivery, 
which resolved following a ten percent dextrose bolus. Fifteen neonates had severe 
hypoglycaemia: four were managed with a single dose of glucagon and 
hydrocortisone and eleven required a dextrose cocktail to maintain euglycaemia. Six 
of these eleven neonates required a 12.5% cocktail, two required a 15% cocktail and 
three required a 20% cocktail.  
 
iv. Radiological and other special investigations 
 
Thirty-three (66%) neonates had long bone x-rays performed. Of these thirty-three, 
eighteen neonates (55%) had long bone changes in keeping with congenital syphilis. 
These included metaphyseal translucent bands, periosteal reactions, and the 
“ratbitten” appearance of  “Wimberger sign”. The bones commonly affected were the 






























Definitions (pertaining to figure 16)  
Hypoglycaemia (within 24 hours of birth) HGT < 2.6 g/dl 
Anaemia (within 24 hours of birth) Hb < 11 g/dl 
Thrombocytopenia (within 24 hours of birth) Platelets < 150 x109 /L 
Coagulopathy (within 24 hours of birth) Deranged clotting profile (Prolonged INR/PTT/ low fibrinogen) 
Conjugated hyperbilirubenaemia Conjugated bilirubin > 20% of total bilirubin 
Hepatitis  Transaminitis (AST /ALT  > 40 U/l) 
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Thirty-two neonates had cranial ultrasound scans performed of which twenty-three 
(72%) where abnormal in varying degrees (table 4). Abnormalities in the neonates 
who demised were all noted within the first three days of life. Cranial ultrasound 
scan findings in the eight neonates who survived were all noted in the first week of 
life.  “Cerebral oedema” is often overcalled or misdiagnosed. Periventricular flares 
(PV) and Grade 1 and 2 IVH’s are considered insignificant and all surviving 
neonates with these abnormalities had no neurological sequelae on discharge.  
 
Findings Total number  (n=23) Survivors (n=8) Deaths  (n=15) 
Mild changes 9 5 4 
PV flares only  1 1 0 
Grade 1 or 2 IVH’s 8 4 4 
Moderate/uncertain changes  7 3 4 
Grade 3 IVH (unilateral) 2 2 0 
“Cerebral oedema” only 5 1 4 
Severe changes 7 0 7 
Bleeds with PVL 1 0 1 
Bleeds with cortical infarcts and PVL 1 0 1 
Bilateral grade 4 IVH’s with hydrocephalus and PVL  2 0 2 
Bleeds with dilated ventricles  3 0 3 
Table 4: Cranial ultrasound scan findings  
 




Forty-nine neonates (98%) who were treated with antibiotics at birth had a septic 
screen performed, including a blood culture. Forty of these forty-nine neonates 
(82%) had a raised CRP of more than ten within forty-eight hours of birth. The 
median CRP was 62.95 mg/l (IQR 38.2 - 106.6 mg/l). Six neonates (12%) had 
culture positive sepsis, more than seventy-two hours after birth, and therefore 
presumed to have hospital acquired infections.  One neonate who subsequently 
demised on day nineteen of life had two positive blood cultures:  Extended spectrum 
beta-lactamase (ESBL) Klebsiella pneumonia on day six and Candida parapsilosis on 
day 12. One neonate with ESBL Klebsiella pneumonia sepsis demised on day 
twenty-one of life (figure 17).  
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Figure 17. Positive blood cultures  
 
vi. Neonatal serology 
 
The following table depicts the neonatal serologic test results (table 5). 
Table 5. Results of neonatal serology 
 
RPR titres were known in twenty mothers and their babies. Five (25%) of these 
neonates had titres at least four times or more than their mothers (figure 18).   
 
Positive blood cultures                  








 Positive  on day 6 	

Patient 3	
 ESBL klebsiella pneumonia and Candida parasilos	

Positive on day 6 and day 12 
respectively 	

(demised on day 19) 	

Patient 4 	
 ESBL Kliebsiella pneumonai 	

Positive on day 4	

(demised on day 23) 	

Patient 5	
 Enterococcus faecium 	




 Positive on day 6	  
Tests and titres  Number (n=50) 
Nontreponemal test  
RPR positive  49 
RPR insufficient  1 
RPR titres  








TPHA positive  16 
TPHA not done 34 
RPR and TPHA positive  15 
 55 
Figure 18. Relationship of neonatal titres to maternal titres (n=20) 
 
 
vii. Level of care required 
 
The sickest neonates i.e. those requiring intubation and/or inotropes were admitted 
into ICU. High care was reserved for those unwell neonates who required support in 
the form of CPAP but had no other features of severity warranting ICU admission. 
The low intensity unit was for well neonates who required admission for monitoring, 
observation and/or antibiotics (figure 19). 
 

















































Low intensity unit (n=5)	
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Figure 20. Maximum mode of respiratory support required from birth (n=50) 
 
 
Figure 20 depicts the maximum mode of respiration support required from birth. The 
median duration of ventilation for the eleven survivors was 4.5 days (IQR 4-6.5 
days). Nineteen neonates (38%) required inotropes; sixteen for more than twenty-
four hours and three for less than twenty-four hours.  
 
Twenty-five neonates (50%) required blood products with eighteen of these twenty-
five neonates requiring multiple products (figure 21). One neonate did not receive 
products due to limitation of care.  
 
Figure 21.  Blood products transfused (n=25) 
 
Three neonates were referred to district hospitals for ongoing care when they were 
stable and off respiratory support.  The mean duration of hospital stay for the seven 



























































viii. Antibiotics  
 
Forty-eight neonates (96%) were treated appropriately. All neonates who survived 
for more than ten days received a full ten day course of intravenous penicillin as per 
the unit protocol. One symptomatic neonate who demised on day twenty of life, with 
a RPR titre equal to the maternal titre of 1:64, was inappropriately treated with a 
single dose of intramuscular penicillin. This neonate’s mother had clinical signs of 
secondary syphilis at delivery (condylomata lata).  Another symptomatic neonate 
was treated with only seven days of penicillin. The course was written up for ten 
days but inadvertently stopped on the prescription chart after seven days. The fifteen 
neonates who survived for less than ten days were treated with penicillin until the 
day of demise.   
 
Twenty-seven neonates (54%) were notified. 
 
ix. Outcomes and follow-up 
 
 
Figure 22 depicts the outcome of the fifty cases.  
 










28 well with no 






















Medium term neurodevelopmental outcome was known for eleven of the thirty-one 
survivors:  
 
1. Ten had documented normal development: 
• Three neonates on formal infant neurodevelopmental assessments at twenty 
weeks corrected GA  
o One of which had a unilateral grade 3 IVH during admission  
• One at two months  
• One at three months  
• Two at four months  
• One at thirteen months 
• One at twenty months  
• One at thirty one months  
 
2. The neonate who was diagnosed HIV positive on a birth PCR had development 
delay on follow-up at three months.  
 
The second neonate with a unilateral grade three IVH was transferred to a secondary 
level hospital on day eight of life and lost to follow-up. The term neonate with 
seizures was also lost to follow-up.    
 
Despite the recommendation for repeat testing at three months, no documentation or 















i. General characteristics 
 
 
Nineteen neonates demised (38%). In this group, thirteen mothers (68%) were 
unbooked and eleven mothers (58%) were under the age of twenty-five. However, 
neonates born to unbooked mothers, did not have a statistically significant increased 
risk for death although there was a trend towards this ([RR], 1.7; CI 0.7-3.8).  No 
mother in this group of nineteen was fully treated with sixteen (84%) mothers 
untreated; thirteen as a result of being unbooked and three who tested negative at 
booking and had no repeat testing performed after thirty-two weeks. Three mothers 
were partially treated as a result of preterm delivery (n=1) and late booking (n=2). 
One twenty-eight year old, unbooked mother, who delivered a preterm baby at thirty-
two weeks GA, had a previous intra-uterine death (IUD) secondary to syphilis 
confirmed on histology two years prior to the current pregnancy. Her baby 
subsequently demised on day three of life. It was unknown whether she or her 
partner was treated in the previous pregnancy. Higher maternal serological titres of 
more than 1:64 were not associated with a significantly increased risk of neonatal 




There were no statistically significant differences between the deaths and survivors 
in terms of gestational age (p = 0.15), birth weight (p = 0.08) or maternal age (p = 
0.51). The median gestational age of the neonates who demised was thirty-three 
weeks (IQR 30-36 weeks) and the mean birth weight was 1717 grams (+/- 608 
grams) (figures 23, 24).  Prematurity  (GA < 38 weeks) had no statistically 
significant effect on mortality ([RR], 3.4; 95% CI, 0.5-22); neither did a low birth 
weight (< 2kg)  ([RR], 1.6; 95% CI 0.7-4.4).  Our study population had more male 
than female neonates; however gender had no statistically significant effect on 
mortality ([RR], 1.2; 95% CI 0.5-2.6).  
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Figure 23. Box and whiskers plot showing gestational age comparison between deaths and 
survivors  
 
Figure 24. Comparison of birth weights in deaths and survivors 
 
 
ii. Clinical signs  
 
 
The five most common clinical signs in the neonates who demised were:  
 
1. Respiratory distress 19 (100%) 
2. HSM 15 (79%)  
3. Petechiae 13 (68%) 
4. Pallor 12 (63%) 



























































































Overall, the neonates who demised had lower median platelet and haemoglobin 
counts at delivery together with a higher median birth CRP. However these were not 
statistically significant  (p=0.91 and p=0.45 p = 0.87 respectively) (figures 25, 26, 
27).  Eleven (58%) of the nineteen neonates who demised had a haemoglobin level 
less than 11 g/dl at birth, however although there was a strong trend toward 
mortality, it too was not statistically significant (p = 0.07).  
 
Figure 25: Platelet counts at birth in deaths (n=18) and survivors (n=31  
 
Figure 26: Haemoglobin levels at birth in deaths (n=18) and survivors (n=31) 
 




































































iii. Level of care and risk factors for death 
 
 
Blood gases obtained from the umbilical cord at delivery were known for eleven of 
the neonates who demised; the mean pH of which was 7.0 (+/-SD 0.16). All nineteen 
neonates who demised required resuscitation at birth.  Thirteen neonates (68%) 
required intubation. Five in addition, required CPR and two required CPR and 
adrenaline.  Neonates with a low one minute Apgar score of less than five were 3.5 
times more likely to demise than neonates with a one minute Apgar score of five or 
more ([RR], 3.5; 95% CI 1.6-7.7). Following resuscitation, a five minute Apgar score 
that remained at five or less than five was associated with an increased risk of 
mortality (table 6).  
 
Figure 28 demonstrates the comparative level of care required in the deaths and 
survivors. Eighteen out of nineteen neonates who demised, required admission to 
ICU. The need for intubation within twenty-four hours of birth was associated with 
an increased risk of mortality (p=0.009) as was the need for inotropes (p=0.006). In 
the eighteen neonates who demised, the median duration of ventilation was three 
days (IQR 2-5 days). The median day of death was 4.5 days (Range 1-24 days).   
 
Figure 28. Level of care in deaths and survivors  
 
Hypoglycaemia was a common clinical finding amongst the neonates who demised 
(63%); however the relative risk of death was not statistically significant. 
Coagulopathy at birth, requiring blood products was associated with a statistically 
significant increased risk of mortality as were moderate to severely abnormal cranial 





































































Investigation  Relative risk of 
death 
Significance 
Hydrops fetalis 2.6 95% CI 1.4-4.8 P=0.003 
Low 1 minute Apgar score < 5 3.4 95% CI 1.6-7.7 P=0.001 
Low 5 minute Apgar ≤ 5 2.9 95% CI 1.5-5.3 P= 0.001 
Coagulopathy  2.2 95% CI 1.1-4.3 P= 0.03 
Abnormal cranial ultrasound scan (excludes PV flares and mild IVH’s) 3.5 95% CI 1.8-6.9 P = 0.0002 
Hypoglycaemia (HGT < 2.6 g/dl) 1.4 95% CI 0.7-3.1 P= 0.32 
Thrombocytopenia (Platelet count < 150 x 109/l) 1.1 95% CI 0.5-2.2 P= 0.81 
Raised CRP > 10mg/l 1.5 95% CI 0.5-2.3 P=0.43 
























Figure 29. Management of the eleven hydropic neonates   
 
There were a total of eleven hydropic neonates of which eight demised. Hydropic 
neonates had an increased risk of mortality ([RR], 2.6; 95% CI 1.4-4.8), requiring 
intubation and inotropes. All eight neonates who demised required resuscitation at 
birth. Seven of these eight neonates were intubated, six of which also required 
inotropes with only one hydropic neonate who demised managed with CPAP (figure 
29).  One extremely unwell hydropic neonate was ventilated for nineteen days until 
the day of demise.  
 
11 hydropic neonates  




9 Demised 7 
Survived  
2 

















In 1999, the World Health Organization (WHO) approximated that 12 million new 
cases of syphilis occur worldwide each year with one third of new cases occurring in 
Africa alone.61 Almost a decade later, in 2008, the WHO estimated that globally, 
1.86 million pregnant women per year are infected with syphilis and that a large 
proportion are inadequately or poorly treated.56 With a presumed 45-70% probability 
of vertical transmission, the estimated number of cases of congenital syphilis ranges 
between 700 000 and 1.5 million annually accounting for an estimated 420 000 to 
600 000 perinatal deaths through stillbirths and neonatal deaths.4 Developing 
countries bear the brunt of the infections with 3-15% of women in their reproductive 
age infected with syphilis.62 In Sub-Saharan Africa a figure of 10% is quoted, with 
congenital syphilis being the most common cause of perinatal mortality, accounting 
for 26% of stillbirths and 11% of neonatal deaths.5,63  
 
Despite the initiation and funding of a South African National Syphilis Screening 
Programme by the Department of Health in the early 1980s, syphilis prevalence in 
South Africa is not declining. According to the 2011 National Antenatal Sentinel 
HIV & Syphilis Prevalence Survey, South Africa’s syphilis prevalence rate has 
shown a 0.1 % increase from 1.5 % (95% CI 1.4-1.7) in 2010 to 1.6% (95% CI 1.5-
1.8) in 2011. Among pregnant women attending antenatal clinics, there has been an 
overall decrease in syphilis prevalence from 11.2% in 1997 to 1.6% in 2011.5,64 
However, the syphilis prevalence rate among antenatal women in the Western Cape 




Data from the Perinatal Problem Identification Programme (PPIP) parallels this, 
showing a steady increase in the percentage of births in serologically positive 
pregnant mothers in the Metro West area of the Western Cape (GSH, Mowbray 
Maternity Hospital, New Somerset Hospital and MOUs to these drainage areas) with 
0.8% of births occurring in serologically positive mothers in 2011, 0.9 % in 2012, 
and 1.2% in 2013. Perinatal deaths from congenital syphilis in the Metro West area 
also showed an increase between 2011 and 2013, of 3% to 3.5 % respectively.65  
Our study showed a symptomatic congenital syphilis incidence rate of 0.13% (1.3 
per 1000 live births), taking into account inborn deliveries only and the 5500 
deliveries per annum at GSH. Compared to international studies in developed 
countries, this incidence rate is more than double the WHO threshold for elimination 
of congenital syphilis of 0.5 per 1000 live births.46,48 However, compared to studies 
in other socioeconomically disadvantaged countries such as Brazil and the 
Colombian Pacific Coast, our rate is lower.43,49 Recent South African statistics 
pertaining to congenital syphilis is limited. One South African study quoted a 
congenital syphilis rate of 10% amongst stillbirths.44 Taking into account the number 
of notified cases of congenital syphilis cases per annum in the Western Cape, a 
decreasing trend is noted: 127 in 1998, 66 in 1999 and 47 in 2000.66 Considering that 
there were 60 313 recorded live births in the Western Cape in 2000, the congenital 
syphilis incidence rate was 0.08%, which is lower than our study rate.  However, as 
only 27 neonates (54%) in our study were notified, underreporting, rather than an 
actual reduction in congenital syphilis cases, may be a contributing factor to the 
lower congenital syphilis rate in 2000.  Provincial rates for congenital syphilis are 
lacking; a prevalence rate of 0.7% was quoted in both Baragwanath and Kalafong 







i. General characteristics  
 
In our study the majority of mothers with syphilis were young and primiparous. 
Coloured mothers were predominant (n=45) with a small number of black mothers 
(n=5) and no Caucasian mothers. This finding of predominantly Coloured mothers 
was unexpected and could not be fully explained by the geographical locations or 
drainage areas that GSH serves, as the percentage of Coloured and Black mothers 
utilizing these services are almost equal (fifty-two percent are Black and forty-six 
percent are Coloured).  The absence of Caucasian mothers may be explained by the 
small percentage (2%) that utilize GSH services.67 Study populations of 
predominantly young, non-Caucasian mothers was noted in Canada, USA and Brazil 
and may be a consequence of lower socio-economic status in these population 
groups.49,52,53 However there were no studies identified, either internationally or in 
South Africa, which commented on a higher prevalence of syphilis in the Coloured 
population specifically. Similarly the 2011 South African National Antenatal 
Sentinel HIV & Syphilis Prevalence Survey does not  elaborate on individual 
population groups with syphilis.64 In our study, there were no apparent explanations 
for why this maternal population group had a higher rate of syphilis infection with no 
identifiable unifying characteristics in these mothers.  
 
ii. Modifiable factors: Patient  
 
There have been no large reported case-series of congenital syphilis following 
appropriate maternal treatment.15,46,50,51,49-51  This is supported by our study finding of 
congenital syphilis in predominantly untreated or inadequately treated mothers. 
Access to antenatal care, including syphilis screening, during pregnancy is generally 
poor in developing countries, with only 68% of pregnant women receiving antenatal 
care and often only after the first trimester.  
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However, South Africa is one of the few African countries where this is not the case, 
as more than 90% of pregnant women have at least one antenatal care visit with 
74.5% of these women being tested for syphilis during their pregnancies.41,69 In our 
study, despite serological confirmation of syphilis in more than three quarters of 
mothers, the overall maternal treatment rate was extremely poor – this was a 
dominant feature from other studies too.47,49,50, This may be explained by the timing 
of maternal diagnosis in relation to delivery, with more than 70% of mothers being 
diagnosed at delivery. This was largely a product of failure to access antenatal care 
on the part of mothers, as evidenced by the high percentage that were unbooked and 
late booking beyond the first trimester in those mothers who did book.  This 
phenomenon of poor health seeking behaviour in pregnancy contributing to 
congenital syphilis rates was noted in other developing countries.47,49,54 A Ugandan 
study identified some of the reasons why women choose to not access antenatal care. 
This was influenced by parity where primigravida mothers were less likely to seek 
health care. Other factors included perceived high cost and disillusionment with the 
health system. Furthermore, some women failed to understand the relevance of 
antenatal care.70 In our study population, documentation for why mothers were 
unbooked was poor. Access to health care was unlikely a factor as all mothers lived 
in urban areas close to health facilities. Lack of education and insight may have 
played a role, as the unbooked mothers tended to be younger and primiparous, which 
were findings from other studies too.45,48 However this was not supported by the 
Ugandan study which found that marital status, religion and education had no effect 
on health seeking behaviour.71 Substance use was a likely contributing factor, as all 
mothers who used substances were unbooked and of a younger age. Taking into 
account that multiparous women with term deliveries were also unbooked, there 
were possible underlying unidentified socio-cultural factors at play. The influence of 
social factors on maternal antenatal care, syphilis diagnosis and treatment was noted 
in studies from both the developing and developed world with incarceration, 
substance use and prostitution mentioned as possible contributing factors. 46,71 
However these social factors may be more complex and multi-faceted as Almeida et 
al identified married women with a single sexual partner and more than eight years 
of education as having higher rates of infection.54 
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iii. Modifiable factors: Clinical/personnel  
 
In terms of health-worker related failures, our study highlighted numerous 
modifiable elements. Failure to repeat syphilis serological tests after thirty-two 
weeks gestation in those mothers who booked early and tested negative at booking, 
as per National Department of Health Protocol, resulted in those mothers being 
untreated. An initial negative test may have been a true negative where an uninfected 
mother in early pregnancy was infected at a later gestation. A more plausible 
explanation is a false negative test result, which occurs in very early infection before 
seroconversion and the production of antibodies (“window period”) or as a result of 
the prozone phenomenon during the period of seroconversion. High antibody titres in 
undiluted maternal serum inhibit agglutination and the formation of antigen-antibody 
complexes causing a false negative test result. Liu et al demonstrated that there was 
an increased odds of the prozone phenomenon occurring during pregnancy ([OR], 
4.123; p= 0.015).72 Serial dilutions of serum will prevent this phenomenon and is in 
fact recommended practise in areas of high syphilis prevalence.73 However, cost 
limits its routine use in our setting. This is the rationale behind repeat testing after 
thirty–two weeks gestation or in those situations where clinical suspicion of maternal 
syphilis is high. This means that, in our study, failure to repeat serology, perform a 
dilution test or empirically treat the mother with a ‘possible syphilitic rash’ were 
modifiable health worker related errors. These factors need to be addressed in order 
to attain the WHO target for syphilis elimination of more than 95% coverage of 
syphilis testing for pregnant women.74 More importantly, maternal syphilis is an 
independent risk factor for mortality in neonates and infants.75  
 
Partner tracing and treatment of partners was extremely poor; this was a finding from 
a number of other studies too.53,54 Maternal re-infection was the likely reason for 
symptomatic congenital syphilis in the baby born to the only fully treated mother, 
and possibly the reason for the mother with a previous IUD secondary to syphilis 






It was unknown whether the second mother or her partner was treated after the 
delivery of an IUD; if either was untreated this was a modifiable health-worker 
related failure. Partner tracing has been associated with a threefold improvement in 
the outcome of pregnancy.76 
 
iv. Modifiable factors: Health system  
 
Possible health system factors that may have contributed to mothers not being re-
tested for syphilis or not booking include resource limitations such as stock shortages 
(e.g. of rapid testing kits) or overburdened health workers and health systems (e.g. 
lack of antenatal sisters or long waiting times). However, in our study due to absent 
documentation these health system factors were unknown.   
 
The introduction of rapid syphilis serological tests in antenatal clinics is a novel 
health system factor. In our study, 16 (43%) of the 37 mothers who tested positive, 
were diagnosed on rapid tests with the remaining 21 mothers confirmed positive on 
formal serological testing. In areas where laboratory access is readily available such 
as in urban tertiary centres, rapid testing is less frequently performed explaining why 
the majority of booked mothers, receiving antenatal care at GSH, were diagnosed on 
formal testing. Fourteen of the rapid tests performed were at delivery largely in the 
unbooked mothers to facilitate rapid diagnosis and dictate immediate neonatal 
management. A South Africa rural study in KZN demonstrated that the addition of 
on-site syphilis testing in areas with laboratory access, did not offer additional 
benefit; it did not lead to improvement in treatment rates or a reduction in perinatal 
mortality. However in light of their cost-effectiveness, rapid turn-around time of 
results as well as their high sensitivity (85-98%) and specificity (93-98%) rapid tests 







i. General characteristics  
 
There is a well known association between untreated maternal syphilis and preterm 
delivery with an incidence of between 10-40%.2,5 Annually, according to the WHO, 
270 000 premature and low birth weigh neonates are born as a result of maternal 
syphilis infection.5  
 
In our study, prematurity was a dominant feature with forty-two out of the fifty 
neonates born with a GA of less than 38 weeks at birth. Spontaneous vertex 
deliveries were the most common delivery mode in premature neonates (n=25); 
however in the case of caesarean sections not all mothers who delivered premature 
neonates were in spontaneous labour with indications for the caesarean sections 
including foetal distress, umbilical cord prolapse and placental abruption. In some of 
these cases preterm delivery may have been unrelated to congenital syphilis. The 
mean birth weight in our study population was less than 2kg. This was lower than 
findings from other studies in the USA, UK, Thailand and Papua New 
Guinea.46,50,52,55 However both the birth weight and GA findings were similar to those 
from another South African study performed at Tygerberg Hospital in the early 
nineties.42 
 
Our study finding of only one twin being symptomatic for congenital syphilis was 
noted in a number of older studies.78 
 
ii. HIV exposure 
 
The complex interaction between adult HIV and syphilis infection has been 
extensively studied with HIV impacting on syphilis transmission rates as well as 
clinical presentation.79 There were only seven HIV exposed neonates in our study 
with one confirmed infected case via in-utero transmission out of the three tested.  
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This small percentage of HIV exposed neonates is likely a product of the political 
commitment and advocacy toward HIV prevention and treatment in the recent years 
at both a global and national level. This rate of 14% is similar to the background rate 
of HIV positive mothers at GSH.60 This differs from the findings of a study in 
Johannesburg from more than twenty years ago before access to ART where the 
incidence of HIV infection in mothers with syphilis was 3 times greater than that of 
the total obstetric population at the time.43 
 
iii. Clinical signs  
 
The commonest clinical sign in our study was respiratory distress. More preterm 
neonates, with respiratory distress at birth, were intubated as compared to term 
neonates although this was not statistically significant. In the face of a largely 
unbooked maternal population with poor antenatal care, it is likely that most 
premature neonates were steroid immature and therefore at increased risk for hyaline 
membrane disease (HMD). However, differentiating between HMD and pneumonia 
secondary to syphilis poses diagnostic difficulties and they are often 
indistinguishable on chest x-ray.42 It is possible that those neonates treated for HMD 
may have had a congenital pneumonia secondary to syphilis.  
 
Our study findings of HSM, petechiae, pallor and jaundice were common clinical 
signs in symptomatic groups of neonates from other study populations.46,47,55 
However, none of our cases had rhinitis or the “syphilitic snuffles” which is quoted 
to be in the range of 4-22% of neonates, and may be the earliest presenting sign.2,47 
Radiological abnormalities, despite being noted in more than half of neonates who 
had long bone x-rays performed, were lower than rates of 75-100% quoted in the 
literature.2,21 Long bone x-rays are not a routine investigation in our protocol and 17 
of our study neonates did not have one performed; this may be a reason for the lower 




Our study was one of the few that reviewed placental weight in relation to birth 
weight. The placentae overall were noted to be heavier, more so in those neonates 
with a birth weight of more than 2 kg in keeping with the findings of Malan et al.19 
The value of placental weight as a clinical sign is largely unrecognised by clinicians, 
as evident by the poor documentation in the medical notes. Its more routine use 




iv. Laboratory derangements 
 
Hypoglycaemia was one of the commonest laboratory derangements noted in more 
than half of our study population. Fifteen of these twenty-seven neonates (55%) had 
severe hypoglycaemia requiring glucagon and hydrocortisone or higher dextrose 
containing cocktails. The greatest risk period was within the first twenty-four hours 
of birth, usually the period soon after delivery, on an initial glucose check. Based on 
the longer duration and more aggressive intervention required in those neonates with 
severe hypoglycaemia, the aetiology was likely multi-factorial. Possible reasons may 
be related to increased metabolic demands compounded by the complications of 
prematurity such as hypothermia, reduced glucose stores as well as delay in initiation 
of feeds or fluids. There have been case reports of hypopituitarism as a result of early 
congenital syphilis which may a cause for prolonged hypoglycaemia in these 
neonates; however, this was unlikely in our study population as a result of eventual 
resolution of hypoglycaemia with no other systemic features suggestive of 
hypopituitarism.80 Our findings indicate that despite hypoglycaemia not being a 
statistically significant risk factor for death, it should be anticipated in neonates with 
congenital syphilis. Preventative strategies such as intravenous fluids and early 
feeding should be instituted timeously together with regular dextrose monitoring in 
the first twenty-four hours of life. The finding of hypoglycaemia has not previously 




v. Serological testing 
 
A number of studies that assessed the neonatal effects of inadequate maternal 
treatment found that clinical, radiological and laboratory evidence of congenital 
syphilis was uncommon with some studies quoting rates of asymptomatic neonates 
in the range of 75-90%. The diagnosis of neonatal syphilis hinged on maternal 
serological testing and treatment history.4,43,49,51  
Current CDC guidelines recommend testing of all exposed neonates and consider 
titres that are fourfold higher than the maternal titres as significant. Lower titres may 
be considered significant in the face of clinical signs or inadequate maternal 
treatment. As per CDC guidelines, our study population were all “proven/highly 
probably congenital syphilis” based on clinical signs alone. All our study cases were 
immediately initiated on penicillin without awaiting serological test results. Our 
findings suggest that a symptomatic neonate together with a maternal history 
suggestive of untreated syphilis is likely to have a positive test result. Taking into 
account that one of the major difficulties in confirming congenital syphilis in 
resource poor settings is the absence of sophisticated laboratory tests, our findings 
suggest that serological testing for syphilis is not essential in making the diagnosis 
when clinical signs are overt and maternal history is highly suggestive.45,23 Even in 
areas where serological testing is easily accessible, diagnosis is not always 
confirmed, with some studies quoting negative nontreponemal test results between 
20-30% in those neonates who met the case definition for congenital syphilis.44,51,49     
We found that in those cases where both maternal and neonatal titres were known, 
three quarters of neonates had titres less than fourfold the maternal titres despite 
being symptomatic. This is why serological syphilis tests and titres are not routinely 
performed in all exposed neonates in our unit. The focus is rather on a thorough 
clinical examination and immediate initiation of empiric treatment in symptomatic 
neonates, without awaiting serological test results. In asymptomatic neonates, the 
identification of those born to poorly treated mothers is paramount to ensure a single 
dose of intramuscular penicillin is given, in order to treat the two thirds of potentially 
infected cases. A study by Paryani et al demonstrated that this single penicillin dose 
as treatment was as efficacious as a ten day course in asymptomatic neonates; this is 
supported by current WHO recommendations, especially in a resource poor setting.81 
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vi. Morbidity and predictors of mortality  
 
In our study, the majority of neonates required aggressive intervention and care.  A 
total of 34 (68%) neonates required admission into ICU, 29 of which were intubated 
and 19 of which required inotropes. Eighteen of the ICU admissions demised, with 
all 18 deaths requiring intubation (12 requiring HFOV and 6 requiring IPPV) and 12 
neonates requiring inotropes. The cost implications of caring for neonates with 
congenital syphilis are well known. In addition to preventing significant neonatal 
morbidity and mortality, this is the rationale behind screening for syphilis even in 
areas with a low syphilis prevalence.82 One study quoted adjusted costs of caring for 
an infant with syphilis of more than three times that of caring for an infant without 
syphilis.83 This is compounded by the extended duration of hospital stay, which is 
noted on average to be more than 7.5 days longer than that of an infant without 
syphilis.82 Overall term neonates without congenital syphilis admitted to our unit 
tend to have a shorter admission time than premature neonates. Our study findings 
however demonstrated that the term neonates with congenital syphilis had a mean 
duration hospital stay of 18 days. Other than the resultant cost implications, there is 
an associated psychological component of prolonged hospital stay with both 
maternal and neonatal implications pertaining to establishment of maternal-infant 
bonding.  
 
A study that was most closely related to ours was from the latter part of the 1990s in 
Papua New Guinea. Their case definition for congenital syphilis was identical and 
they too addressed risk factors for death. Their sample size was larger than ours with 
a comparative control group of neonates without syphilis; however detail regarding 
the level of care required (ICU/intubation etc.) in those that demised was lacking. 
Low birth weight less than 2 kg was a statistically significant risk factor for death.55 
This finding was not supported by our study. This may be accounted for by the study 
time period, which was more than fifteen years ago in the largely developing country 
of Papua New Guinea. It is possible that the low birth weight neonates with 
congenital syphilis were sicker at birth and born at a time when resources available 
for low birth weight neonates may have been lacking.  
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We found that two strong predictors of mortality were one and five minute Apgar 
scores of less than five with the need for intubation and inotropes within the first 
twenty-four hours of life associated with a statistically significant increased risk of 
death. The mean cord gas pH of 7 in those neonates who demised was suggestive of 
intrapartum compromise with all neonates being unwell from birth. The lack of 
improvement in the five minute Apgar score suggests need for prolonged 
resuscitation. These findings of low Apgar scores in neonates with congenital 
syphilis was noted in an older study from a large tertiary hospital in the Western 
Cape where a mean one minute Apgar score of 4 (range 1-9) and a mean 5 min 
Apgar score of 6 (range 4-10) was recorded. None of the twenty neonates in this 
study demised.42  
 
We noted that just under half of our study population were anaemic at birth with the 
neonates who demised having a lower median haemoglobin level at delivery. 
However this difference was not statistically significant with anaemia not being a 
significant risk factor for mortality. This finding was supported by the study from 
Papua New Guinea.55 However, we did find that neonates who were coagulopathic at 
birth had a statistically significant increased risk of death. There were no other 
studies that specifically mentioned this complication. Our study was also one of the 
only studies that reviewed cranial ultrasound scan findings in neonates with 
congenital syphilis. Severe abnormalities were noted in the group that demised which 
was associated with a statistically significant increase in mortality. However there 
were likely confounding variables associated with these abnormalities, related to 
prematurity and birth asphyxia. Due to our small sample size we did not correct for 
these confounders.  
 
We noted that hydrops fetalis was a statistically significant independent risk factor 
for mortality. Eight of eleven hydropic neonates demised with seven of these 
requiring intubation and six requiring inotropes within twenty-four hours of birth. In 
light of the high mortality of hydropic neonates (72%), limitation of care may be 
considered in those that are critically unwell who require aggressive management in 
the first twenty-four hours of life. This may be particularly relevant in resource-
constrained settings.  
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vii. Treatment and Notification  
 
Disease notification is a vital public health initiative; its use as a monitoring tool 
helps to evaluate the extent of the problem and aims to reduce the number of 
congenital syphilis cases. In our study, notification of congenital syphilis was 
extremely poor with just over half of our study population being notified. The 
identification of poor notification by health workers was demonstrated by Ballot et al 
in the early 1990s in Johannesburg and yet more than twenty years later we are still 
failing in this regard.43 
 
A positive finding was that the majority of our study population was appropriately 
treated. Both incorrectly treated cases involved modifiable health worker failures. 
The first case involved failure to adhere to the unit protocol where a symptomatic 
neonate was treated with a single dose of intramuscular penicillin. It is possible that 
in the second case in the face of an elevated CRP, the attending physician overlooked 
the diagnosis of syphilis and stopped antibiotics after a course of treatment for sepsis.  
 
 viii. Follow-up  
Outcome was known for 11 of the surviving neonates with 10 having documented 
normal development and only one neonatal with signs of developmental delay (HIV 
infected). There are no large studies evaluating ultimate outcome in neonates with 
congenital syphilis.82  
 
One small study with a five-year follow-up period demonstrated more adverse 
outcomes than our study such as seizures, visual impairment and death.49 An 
additional study from Brazil found that most of the neonates evaluated up to five 
years had a favourable outcome.51 
We failed to locate any repeat serological testing performed in our thirty-one 
survivors, which again is a health worker related factor with failure to adhere to the 
unit protocol. A single study found that 68% of their study population was negative 
on repeat serological testing 
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CHAPTER 5: STUDY LIMITATIONS AND CONCLUSION 
1. STUDY LIMITATIONS
In view of maternal syphilis serological testing not being the focus of this study, not 
all neonates born to mothers with syphilis were included. From the literature, it is 
known that two thirds of live born infected neonates are asymptomatic at birth and 
develop signs months to years later. Therefore, we acknowledge that we may have 
overlooked those neonates with later presentations. However, for the purpose of this 
folder review, the symptomatic neonates at birth were of interest. It was also 
possible, although unlikely, that we overlooked those outborn surviving neonates 
who were not notified and had syphilis testing at their delivery hospital; likewise 
those neonates who demised before syphilis serology could be performed.  
Being a retrospective folder review, not all relevant questions were answerable. This 
was mainly due to poor documentation specifically regarding why mothers were 
unbooked and whether partner tracing was sought. Furthermore, because neonates 
were registered at birth under their mothers names, follow-up of HIV PCR or 
serological syphilis testing may have been performed under different names and 
possibly even different folder numbers, explaining the difficulty in tracing these 
results. For this same reason, there was difficulty in tracing neurodevelopmental 
outcome, as some children defaulted follow-up and possibly presented to other 
drainage areas where no record keeping existed.  
Our small sample size and the lack of a control group meant that our study was not 
powered to detect small differences between deaths and survivors. This also meant 





Despite the introduction of a National Syphilis Screening programme more than 
twenty years ago together with a large proportion of pregnant women having access 
to antenatal care, congenital syphilis is still prevalent in South Africa. Failure to 
access antenatal care, poor partner tracing and a number of modifiable health worker 
related failures contributed to poor maternal diagnosis and treatment. Maternal 
syphilis is an independent risk factor for neonatal mortality. Many neonates with 
congenital syphilis require aggressive interventions and maximum levels of care. 
This dissertation adds to the existing body of research particularly with regard to 
predictors of outcome in tertiary neonatal settings. Hypoglycaemia and hydrops 
fetalis in particular have not been addressed previously. Certain categories of 
neonates have a lower survival rate and guidelines about limitation of care may need 
to be considered in order to optimise resource allocation particularly in resource-
constrained settings. Further research is required to elaborate how best to develop 
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Appendix 1: Data Sheet 
* Fully treated: 3 IM doses of benzathine penicillin weekly for three weeks with the last dose being
given more than one month before delivery
* Partially treated: incomplete doses of penicllin or last dose given less than one month before
delivery





Gravidity and parity 
Booked Yes 
No 
Gestational age at booking 
RVD positive Yes 
No 
Haart (including duration) Yes 
No 
Syphilis test results 
If syphilis positive: at what gestational age was 
diagnosis made? 
Fully treated * Yes 
No 
Partially treated * Yes 
No 
Untreated * Yes 
No 
Reasons for being untreated Lost to follow-up 





Partner tracing Yes 
No 
88 
Anaemia: low haemoglobin level < 11g/dl. Transfusions dictated by GSH unit protocol. 








Need for resusitation Yes 
No 












CNS Intra-ventricular haemorrages/hydrocephalus 
Meningitis 





Skin/mucous membranes Bullae 
Rhinitis 
Fissures/scars 


























Serological tests for syphilus  
Xrays of long bones  
Additional investigations 
CRP  
Positive cultures   
Cranial ultrasound scan    
Management 
Level of care ICU 
 High care 
 Low level care 




Need for iontropes Yes 
 No 
Duration and type of ionotrope  
Need for blood products Yes 
No 
Type of blood product used  
Antibiotic used  
Duration of antibiotic  
Length of hospital stay  
Outcome Death 
 Morbidity 
 Well with no obvious sequelae  
Notified Yes 
 No 
Follow-up given  
Neurodevelopmental outcome  
